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ABSTRACT
Assessing the Photoprotective Effects of Fluorescent Sphingomyelin Against UVB Induced DNA
Damage in Human Keratinocytes
Rebecca Marie Kandell
Non Melanoma Skin Cancer (NMSC) affects 3.3 million Americans each year and results
from Ultra Violet Radiation (UVR) damage to DNA in the form of pyrimidine dimers and
photoproducts [1]–[5]. Cells directly detect the damage and initiate apoptosis, cell cycle arrest, or
DNA repair by modulating p53 and p21 levels [6]–[9]. Current methods of photoprotection
include sunscreen, but controversy over safety of some active ingredients necessitates research
into more natural alternatives [10]–[12]. In particular, 24 hour incubation with bovine milk
sphingomyelin (BSM) has demonstrated photoprotective potential by reducing p21 and p53 levels
in keratinocytes (KRTs) after UV radiation [13], [14]. This thesis aims to expand on past BSM
research by exploring the mechanism for photoprotection. Normally, sphingomyelin (SM) is
metabolically degraded to ceramide which then leads to cell apoptosis [6]. The goals of this thesis
were to characterize a fluorescent SM (FSM) to assess changes in intracellular fluorescence
distribution after various incubation and post-UV exposure times. FSM was deemed functionally
equivalent to BSM by reducing levels of p21 after UV. Furthermore, quantification demonstrated
that FSM trafficking and intracellular fluorescence were independent of continuous incubation
time, warranting further investigation into shorter timepoints like 1 hour. Across several post-UV
timepoints, the 1 hour incubation had a consistently higher average cytoplasmic mean gray value
compared to 24 hour incubation. In addition, the no UV control was significantly lower compared
to the 24 hour and 12 hour post-UV timepoints. No post-UV differences were observed for the 24
hour incubation, suggesting future work is necessary for the 1 hour incubation, which potentially
streamlines future experiments. Two immunofluorescence stains for endogenous SM (lysenin)
and ceramide were also optimized for preliminary fluorescence distribution studies and
iv

colocalization with FSM. Finally, a 3T3 fibroblast spheroid model was utilized as proof-ofconcept for future 3D KRT cultures and depth of dye penetration quantification methods. These
findings suggest FSM is an appropriate model for BSM trafficking, a shorter FSM incubation
time could potentially be adopted in future studies, dual immunofluorescence staining for SM and
ceramide is viable, and spheroids provide a promising model for future 3D KRT studies.
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1. INTRODUCTION
The skin is one of the largest organs in the human body and provides a physical barrier
while regulating temperature and water content, among many other crucial functions [15], [16].
Non-Melanoma Skin Cancer (NMSC) affects approximately 3.3 million Americans each year and
is currently the most commonly diagnosed disease [1], [2], [5]. The common forms of NMSC are
Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC), with BCC representing
about 80% of NMSCs [2], [17] Given the prevalence of NMSC in the human population,
understanding the cause and potential treatments is crucial.
Ultra Violet Radiation (UVR) is mainly responsible for damage to skin and NMSC
occurrence [4]. UVB light (280-320 nm) is the most damaging to skin and causes direct damage
to Deoxyribonucleic Acid (DNA) in the form of cyclobutene pyrimidine dimers and (6-4)
photoproducts which disturb the double helix structure [3], [4]. These two photoproduct lesions
can lead to further DNA mutations like CC->TT base substitutions predominantly referenced as a
‘UV signature mutation’ [18], [19]. Mutations in oncogenes like the p53 tumor suppressor gene
increase the rate of developing cancer such as NMSC [18].
Cells directly detect UV DNA damage with molecular sensors like Mre11, NBS1, and
Rad 50 which initiate the DNA Damage Response (DDR), a group of signaling pathways which
lead to either apoptosis, DNA repair, or cell cycle arrest in order to maintain genome integrity [6].
The tumor suppressor protein p53, also coined the ‘guardian of the genome’, serves as a
transcription factor to regulate genes involved with cell cycle arrest and apoptosis [7], [8]. For
example, p53 activates downstream p21 protein which is a cyclin-dependent kinase inhibitor that
arrests DNA replication to allow time for DNA repair [9]. Skin carcinogenesis can develop when
DNA mutations cause loss-of-function mutations in the p53 tumor suppressor gene leading to cell
evasion of normal DNA repair and apoptosis processes [18], [20]. Repeated exposures to
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environmental triggers (e.g. solar UVR) can cause a progression of NMSC cancer from premalignant lesions to tumors and eventually metastatic lesions [20].
Current methods to avoid NMSC include protective actions like avoiding sun, wearing
protective clothes, and regularly applying sunscreen [12], [17]. Sunscreen is an essential
component of photoprotection, but according to a 2016 poll of US dermatologists, 99% believed
their patients did not apply enough sunscreen or use it according to product guidelines [21].
Furthermore, some controversy exists around certain chemical active ingredients such as
oxybenzone [10]–[12]. Not only has research demonstrated that oxybenzone pollutes the
environment, a 2001 animal study demonstrated endocrine disruption [10], [12]. In addition, a 10year retrospective study of 24,000 patients asserted that 70.2% of patients confirmed positive for
oxybenzone allergies when patch tested [12]. Given the prevalence of skin cancer and
controversy over the systemic safety of oxybenzone, the need for safer, more natural alternatives
is of scientific importance.
Bovine milk sphingomyelin (BSM) has demonstrated photoprotective potential [13],
[14], [22], [23]. Orally administered BSM in mice accumulated in the stratum corneum layer of
the skin and reduced transepidermal water loss after UVB radiation [22], [23]. Furthermore,
research by De Guzman and Campbell have demonstrated that BSM administration to a
monolayer of keratinocyte (KRT) skin cells reduced p21 and p53 levels after UVB compared to
the control [13], [14]. The decrease in both p21 and p53 DDR proteins was correlated with an
increase in photoprotection offered by BSM to KRT cells.
The success of BSM treatment in UVB KRT models has prompted research into the
reason for the observed photoprotection. Sphingomyelin (SM) is normally degraded to ceramide
in the plasma membrane by SMase enzymes [6]. Furthermore, ceramide levels have been
demonstrated to increase after UVB radiation in KRTs which offers photoprotection by
increasing the apoptosis rates of potentially damaged cells [24]–[26]. A current hypothesis for
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SM photoprotection is that exogenous addition to cells increases the amount of ceramide
production through hydrolysis mechanisms and subsequently increases rates of apoptosis in UV
exposed cells. However, the levels of intracellular SM after UVB irradiation in KRTs is less
characterized, and no groups combine exogenous SM treatment with UVB to quantify changes in
intracellular SM levels. Quantifying intracellular SM could answer questions about lipid
homeostasis, trafficking, and mechanisms of photoprotection in a cell. Additionally, fluorescence
imaging methodologies to quantify cellular localization were not employed in past BSM research
[13], [14]. Therefore, the goals of this thesis were to characterize Fluorescent SM (FSM) as an
analogue to BSM and assess the changes in intracellular FSM distribution after different
incubation times and after UV. Different metabolic processes occur in different locations in a cell
(plasma membrane, golgi, endoplasmic reticulum) and trafficking fluorescence location
elucidates mechanisms of metabolism and degradation in a cell [27]. Two immunofluorescence
stains for endogenous SM (lysenin) and ceramide were also optimized and used for a preliminary
fluorescence distribution studies to characterize FSM with colocalization in the future. Finally,
the use of spheroids as a more relevant 3D model was assessed by characterizing NIH 3T3 mouse
fibroblasts as proof-of-concept.
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2. BACKGROUND
2.1 Integumentary System
The skin is an organ member of the Integumentary System and primarily forms a barrier to
protect the body from damage and disease [15]. In adult humans, skin and accessory organs
comprise approximately 16 percent of body weight and cover about 2.0 m2 (22 ft2) of surface
area, making the Integumentary System the largest organ system in humans [15], [28]. Exhibiting
a multilayered and complicated structure, the Integumentary System performs numerous
functions crucial for overall health.
The skin consists of two main layers, an epidermis and an underlying dermis (Figure 1).
Directly beneath the dermis is the hypodermis, also called the subcutaneous, subcutis, or
superficial fascia [15], [28].

Figure 1: The Three Layers of the Skin and Associated Accessory Organs [15].
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Skin thickness varies from 0.5mm lining the eyelids to 4.0mm surrounding the heel of the
feet [28]. Although its main function is protection from Ultra Violet (UV) radiation, injury,
infection, and external stresses, skin also provides thermoregulation, absorption/secretion of
water and metabolites, production of vitamin D, and sensation touch and pain [15]. The epidermis
also dictates cutaneous movement of water and electrolytes because of its high lipid content and
hydrophobic nature [29]. The malfunction of skin in diseases and disorders like cancer
demonstrate the essential function of the Integumentary System and the need to cherish it.
Although the focus of this section is the structure and function of the epidermis, the
dermis and hypodermis play an integral role in skin health. The dermis is a vascularized and
innervated connective tissue layer comprised of connective tissue (collagen and elastin),
fibroblasts, sweat glands, and hair [28]. The dermal papillae form the superficial layer and serve
as an adhesion site and partition between the epidermis and dermis [28]. Dermal papillae also
shunt nutrients from the vasculature to the epidermis which lacks a clear blood supply [28]. The
dermis is divided into the superficial region, which contains the dermal papillae and deeper
region of collagen and fibroblasts [15], [28]. Beneath the dermis lies the hypodermis, a layer
mainly made of adipose tissue and sweat glands [15], [28]. Taken together, the epidermis, dermis,
and hypodermis protect the body from external insults, enable sensory function, perform
thermoregulation, and synthesize Vitamin D and other essential nutrients [15]. The subsequent
sections will focus on the different layers of the epidermis, with an emphasis on the resident
keratinocyte cells and lipid metabolism.
2.1.1 Epidermis
The epidermis is the most superficial layer of skin and first line of defense between the
body and the external environment [15], [28], [30]. About 100 microns thick, this layer is an
avascular and self-renewing stratified squamous epithelial cell structure composed of four layers
(listed from most superficial to deep): stratum corneum, stratum granulosum, stratum spinosum,
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and stratum basale [15], [28], [30]. In thick callous skin (i.e. lining soles of feet, fingertips or
palms of hands), the epidermis has a fifth layer of translucent cells between the stratum corneum
and stratum granulosum called the stratum lucidum (Figure 2) [15], [28].
The skin is comprised of three main cell types: keratinocytes (KRTs), melanocytes, and
fibroblasts [31]. KRTs are the predominant epidermal cell type comprising 95% of total cells
[30]. KRTs exhibit a differential phenotype depending on the layer [30], [31]. They start off as
viable, nucleated, and cobblestone-shaped cells in the stratum basale then undergo remarkable
changes leading to the conventional “flaky” stratified cell phenotype in the stratum corneum [30],
[31]. KRTs also produce keratin, an intracellular fibrous protein and structural component
responsible for the hardness and water-resistance of hair, nails, and skin [32]. The type of keratin
produced depends on the layer and KRT differentiation stage [32].

Figure 2: Layers of the Skin Epidermis [15]. The layers of the skin from most superficial to
deep are Stratum corneum, Stratum lucidum (absent in thin skin), Stratum granulosum, Stratum
spinosum, and Stratum basale.
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KRTs are produced in the basal layer, then undergo keratinization (cornification) as they
push up through the layers of skin and ultimately shed as dead skin flakes from the stratum
corneum [30]. The process of KRT differentiation in the basal layer and shedding at the corneum
is a cyclic process that replaces the epidermis every four weeks [15]. Melanocytes (1-2% of
epidermis cells) and fibroblasts (dermal layer), are also crucial for skin health and cell phenotype
[30].
2.1.1.1 Stratum Corneum
The stratum corneum is the most superficial layer of the dermis made up of 15-30 layers
of flattened, dead, and densely-packed cornified KRTs [15], [28]. These terminally differentiated
KRTs are known as corneocytes because they are flattened and anucleate [15], [16], [28], [30].
Corneocytes, building blocks of the stratum corneum, originate from stratum granulosum KRTs
that rise to the surface before undergoing apoptosis in the corneum [16], [30]. Directly
surrounding the corneocytes is a hydrophobic extracellular matrix (ECM) made of mostly
ceramide, cholesterol, fatty acids, and proteins including filaggrin and keratin [29]. On average,
each KRT cell takes two weeks to rise from the basale to corneum, then another two weeks to
cornify before flaking off in a process called desquamation [30].
Lipids originate from lamellar body secretions by cells in the stratum granulosum [16],
[29]. In a normal keratinocyte, lipids are synthesized during cell differentiation in the granulosum
and packaged into lamellar bodies, small bilayer and circular organelles [29]. In the granulosum,
the concentration of calcium peaks and drops rapidly in the corneum, triggering the exocytosis of
lipid-filled lamellar bodies into the extracellular space of the stratum corneum [16]. The released
lipids are subsequently processed and rearranged parallel to the corneocyte membrane to form a
cornified envelope [33]. The lipids are further metabolized into ceramide which accounts for over
30-40% of lipid weight in the corneum [16]. Cholesterol and sphingomyelin are also present in
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the corneum interstitial space [29]. In total, the high lipid content maintains fluid balance by
preventing water loss [33]. When the skin barrier is disrupted, lamellar body secretion and
sphingolipid metabolism increase to reestablish the hydrophobic barrier [29], [33].
Filaggrin and keratin together compose 80-90% of protein mass in the epidermis [16].
Filaggrin ensures corneum water retention while maintaining barrier function [34]. Filaggrin also
interacts with keratin to form tight bundles and promote cornification [34]. Loss of filaggrin
function can lead to skin conditions like dermatitis, and increases UV sensitivity as demonstrated
by an in vitro skin model [34].
2.1.1.2 Stratum Granulosum and Lucidum
The stratum granulosum, 3-5 layers superficial to the stratum spinosum, is named
because of the grainy appearance of the KRTs [15], [28]. The granular nature is due to
accumulation of keratin and keratohyalin which are bundles of profilaggrin [35]. Lamellar bodies
also accumulate in this layer before cells release the lipid into the stratum corneum [35]. The cells
in the granulosum eventually flatten, lose their nucleus, and differentially terminate before
reaching the stratum corneum [15], [28].
The stratum lucidum is another layer directly above the granulosum, and only present in
thicker skin [15], [28]. The extracellular matrix is filled with a clear protein called eleidin,
derived from keratohyalin [16].
2.1.1.3 Stratum Spinosum
Directly above the stratum basale is the stratum spinosum, a region of 8-10 layers of
KRTs [28]. Cells are anchored by desmosome proteins and keratin [16]. The name of the layer
comes from the desmosome ‘spiny’ appearance after histology staining [15], [28]. Spinosum
KRTs also begin synthesis of keratin protein and lamellar bodies which are secretary lipid
vesicles instrumental in maintaining the hydrophobicity of the skin [15], [33]. Interspersed within
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the KRTs are Langerhans cells, dendric antigen presenting cells that play an integral part in the
epidermal immune response [36].
2.1.1.4 Stratum Basale
The stratum basale, also described as the stratum germinativum, is the deepest layer of
the epidermis [15], [28]. It is a single layer of basal cells, cuboidal-shaped stem cells and
precursors of the epidermal KRT cell lineage [15], [28]. Only 15% of basal cells constantly
undergo mitosis to rapidly produce KRTs that are eventually pushed upward to replace the
previous superficial layer [15], [16]. The remaining basal cells are activated to undergo
differentiation during wound healing [15], [16].
Merkel and melanocytes are non-keratinizing cells scattered among the basal cell layer
[31]. Merkel cells receive and transmit touch sensations to the brain while melanocytes produce
melanosomes and melanin pigment that protect cells from UV radiation [15], [16]. Melanin is upregulated after UV exposure and aids in photoprotection [30]. KRTs and melanocytes have a
collaborative relationship; KRT paracrine factors regulate melanocyte function [31].
2.1.2 Functions of the Epidermis
The epidermis provides innate immunity with a physical barrier and antimicrobial
secretion [15], [28]. From a lipid standpoint, the stratum corneum also maintains water secretion
and prevents water loss from the body due to its high lipid content [16]. The transfer of water
from the stratum corneum is measured by the Transepidermal Water Loss (TEWL) [16]. The high
lipid content in the stratum corneum reduces TEWL, and perturbations of lipid content
demonstrate how TEWL is affected. For example, mouse skin damaged by UV light showed an
increase in TEWL [37]. In addition, severely burned skin leads to massive dehydration because of
increased TEWL [15]. Furthermore, Gaucher and Neimann Pick disease are two disorders of
sphingolipid enzymes that result in dysregulated skin permeation [29].
9

2.2 Non-Melanoma Skin Cancer
Cancer is described as the uncontrollable growth of abnormal cells [38]. Genetically
mutated cells proliferate and form tumors with genomic and chromosomal instability which can
lead to a metastatic cancer [38]. One cause of genetic mutations is UV radiation which enables
mutated cells to ignore normal signaling processes that regulate proliferation and cell death [5].
Skin cancer manifests into two main types: Non-Melanoma and Melanoma.
Non-Melanoma Skin Cancer, abbreviated NMSC, is the most commonly diagnosed
disease and is a significant health concern in terms of incidence rate and economic health care
costs [1], [2]. According to the American Cancer Society, approximately 3.3 million Americans
are diagnosed with NMSC each year [5]. NMSC prevalence has increased by 300% since 1994
and generates over $650 million in US healthcare costs [2], [39].
NMSC takes two main forms – Basal Cell Carcinoma (BCC) and Squamous Cell
Carcinoma (SCC). BCC occurs most frequently in the human population, representing
approximately 80% of all NMSCs [2], [5]. BCC and SCC originate in the basal and squamous
cell layers respectively. In general, BCC rarely yields malignant tumors, while SCCs are more
likely to invade and metastasize [5].
2.2.1 Basal and Squamous Cell Carcinoma
BCC, the most common skin cancer subtype, develops when mutated cells in the basal
layer, the lowest region of the epidermis, become mutated and proliferate uncontrollably [5].
Over 3 million Americans are diagnosed with BCC each year [5]. Although rarely metastatic and
easily treatable in early stages, surgical removal of BCC can leave scars, and identifying cancer
phenotypes is crucial before a large lesion develops [5]. According to the Skin Cancer
Foundation, BCC manifests into five common sore variants (Figure 3): open sore, red irritated
skin, shiny (pearly) nodule, pink growth with elevated border, and wavy scar-like patch [5].
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Figure 3: Types of BCC Tumor Skin Growths [5]. (A) Open Sore. (B) Red Patch of Irritated
Skin. (C) Shiny Bump or Nodule. (D) Pink Growth. (E) Scar-Like Area.
SCC is the second prevalent NMSC subtype and involves cancerous proliferation of the
squamous cells of the epidermis [5]. Over 1 million cases of SCC are diagnosed in the United
States each year, and approximately 8,800 Americans die from the disease [5]. Furthermore, the
incidence of SCC has risen 200 percent in America over the past 30 years. [5].
A small proportion of SCC can metastasize deeper into the dermis, or even spread to
other organs, yielding significant surgical removal and a life-threatening prognosis [5]. SCC
“precancers” like actinic keratoses, actinic chelitis, leukoplakia, and Bowen’s Disease, are often
benign and early stages of SCC [5]. The warning signs of SCC (Figure 4) include a crusty scaly
patch, a bleeding growth, persistent bleeding open sore, and wart-like growth [5]. Early
identification of precancers and abnormal lesions is essential for diagnosing and treating early
stage cancer.
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Figure 4: Types of SCC Tumor Skin Growths [5]. (A) Scaly red patch. (B) Elevated growth.
(C) Persistent open sore that bleeds. (D) Wart-like growth.
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The main cause of skin cancer is prolonged exposure to sun and most cancers occur in skin
areas exposed to sun such as the face, back, neck, shoulders, and ears [5]. However, skin cancer
can develop from artificial sources of light like tanning beds. Certain subpopulations such as the
elderly, fair-skinned, and the immunocompromised are at increased risk of developing BCC [5].
The treatments for BCC and SCC are commonly an outpatient procedure like Mohs
Micrograph surgery, excisional surgery, cryosurgery, photodynamic therapy, and topic
medication [5]. Often a biopsy is needed to make an accurate diagnosis [5].
2.2.2 Melanoma and Merkel Cell Carcinoma
Although less common in the American population, Melanoma and Merkel Cell
Carcinoma (MCC) are invasive, aggressive, and metastatic forms of cancer [5]. Melanoma
involves mutations in the melanocytes of the basal layer, while MCC begins in the Merkel cells
connected to the nerves responsible for the touch sensation [5]. MCC is 40 times rarer than
melanoma, and three times as deadly, killing one in three patients diagnosed with the disease [5].
Although Melanoma and Merkel Cell Carcinomas are more fatal than NMSC, this thesis focuses
on NMSC because it is more prevalent in the human population.
2.3 UV Light
Ultra Violet Radiation (UVR) is a detrimental exogenous agent responsible for genome
damage in all species [4]. In general, UV light is composed of three separate types differentiated
by their respective wavelengths: UVA (320-400 nm), UVB (280-320 nm), and UVC (200-280
nm) [2]. UVA lies closest to the visible light spectrum (700-400nm) on a scale of increasing
wavelength (Figure 5). Differing wavelengths yield differential penetration depths, with UVA
penetrating deeper into the subcutaneous tissue while UVB only reaching the superficial
epidermis/dermis layers [40].
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Figure 5: Differing UV Wavelengths (UVA, UVB, UVC) and Skin Penetration Depths [40].
UVA and UVB are wavelengths of primary concern for skin cancer. UVA radiation penetrates
deeper into tissue while UVB is absorbed by the epidermis. UVB is responsible for DNA
damage.
UVB radiation is the primary concern for skin damage. Comparatively, UVB, although
only comprising 1% of the sun’s total energy, is the most damaging of the three because UVA
does not efficiently generate DNA damage and the ozone in the atmosphere effectively filters out
UVC [3]. Thus, UVB is most relevant to skin cancer and most damaging. Most of the deleterious,
cancer-inducing effects of UVB are caused by direct damage to DNA as described in the
subsequent section [40]. Furthermore, UVR-genome damage incidence is increasing in the world
because of ozone depletion [4]. Assessing the mechanism of damage and potential
photoprotective agents is crucial to prevent the persistence of NMSC and other skin cancers.
2.4 UV-Induced DNA Damage
Deoxyribonucleic Acid (DNA) is the genetic instruction manual for a cell [15]. DNA is a
molecule comprised of two interwoven complementary strands twisted into a ladder shape [15].
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The backbone is made of alternating sugar and phosphate groups joined by four nitrogenous
bases: Adenine (A), Thymine (T), Cytosine (C), and Guanine (G) [15]. Adenine and cytosine
selectively hydrogen bonds with thymine and guanine respectively to form AT and CG base pairs
[41]. Structurally, A, T, C, and G are heterocyclic aromatic compounds, meaning they are organic
compounds with one or two carbon atoms replaced with a different atom (e.g. nitrogen) [41]. C
and T are classified as pyrimidines (one ring nitrogen-carbon compound) and A and G are purines
(two ring structures with pyrimidine fused to imidazole) [15], [41]. Together, the nitrogenous
base and sugar backbone form a nucleotide, the building block of DNA [15]. The order of bases
along the sugar-phosphate backbone determines the genetic code by affecting transcription and
translation [15]. During normal DNA replication, DNA polymerase “proofreads” for errors in
nucleotide insertion along the DNA molecule and mismatch repair enzymes further correct for
deformities in DNA structure [41]. However, if an error in DNA nucleotides is not corrected, the
mutations become permanent [41]. The cell no longer recognizes the DNA as mutated and uses
the incorrect strand as a template for subsequent replication processes [41]. Eventually, the cell
propagates the mutation which can yield a disease phenotype like cancer [41]. Error can occur
either spontaneously or as a result of the environment (i.e. UV radiation).
UV-B radiation leads to the formation of lesions in DNA that alter the structure and form
mutations [3], [4]. The main types of lesions include cyclobutene pyrimidine dimers (CPDs) and
pyrimidine(6-4) pyrimidone photoproducts, also referenced as (6-4) photoproducts [3], [4].
2.4.1 DNA Mutations
When a skin cell is subjected to UV light, the DNA strands absorb a photon of high
energy light which is then used to form extra covalent bonds between bases, forming a dimer or
lesion [4], [18]. The two common mutations caused by UV are CPDs and (6-4) photoproducts;
both involve adjacent pyrimidines (C or T) in the DNA molecule [4], [18]. Adjacent pyrimidines
are weak spots for DNA mutation and are the likely site for UV damage [18]. CPDs form at a T-T
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site; the double bond between the C-4 and C-5 carbons breaks into a single bond and the energy is
transferred to a bond between the C-4 carbons of the adjacent thymine [4], [18]. A ring structure
connecting the two bases and mutating the DNA structure is ultimately formed [18]. On the other
hand, (6-4) photoproducts occur between T-C adjacent bases and results when the C-6 carbon of
the 5’side of the first base covalently binds to the C-4 carbon of the 3’ adjacent pyrimidine
(Figure 6) [4], [18].

B
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Figure 6: DNA Mutations because of UV [18]. (A) T-T adjacent bases. (B) T-C adjacent bases.
(C) After UV, a cyclobutene pyrimidine dimers (CPD) forms. (D) After UV, a (6-4) photoproduct
forms.

Both CPDs and (6-4) photoproducts greatly disturb and distort the DNA double helix,
albeit (6-4) photoproducts to a greater degree [18]. Although CPDs are three times as likely to
occur than (6-4) photoproducts and are more difficult to detect, the order of nucleotides,
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wavelength of light, and location of DNA can all affect the prevalence and nature of the DNA
damage [18].
These mutations can lead to C->T or CC-> TT nucleotide substitutions where a cytosine
is replaced by a thymine during DNA replication, leading to incorrect incorporation of bases into
the genetic code [18]. The CC->TT substitution is so common in cancer cells that it is termed a
‘UV signature mutation’ [18], [19]. When this mutation occurs in oncogenes like the p53 tumor
suppressor gene, the risk of developing skin cancer later increases [18].
UV radiation can also cause several other mutations like purine photoproducts, singlestrand breaks, and double-strand breaks [4], [18]. UVA is also known to create intracellular
damage by the formation of Reactive Oxygen Species (ROS) like singlet oxygen and hydrogen
peroxide [18]. Intracellular proteins and lipids can also absorb UV and generate damaging ROS
[18].
Studies have also demonstrated that UVR can lead to local immunosuppression by the
release of the cytokines TNF-alpha and IL-10, recruitment of macrophages, and decrease in
Langerhans cells [19]. A reduced immune system increases the likelihood that a tumor cell will
not be detected [19].
2.5 DNA Damage Response Cascade
More specifically, how does a cell detect DNA damage and initiate repair before a
mutation is propagated? The answer lies in the DNA Damage Response (DDR), a host of cell
pathways initiated by a damaging agent like UV radiation, ionization, or chemotherapy [6]. Of
particular interest for this thesis is the effects of UVB radiation on DDR initiation and signaling
(Figure 7).
The most important role of the DDR is to maintain the cell’s DNA or genome [6]. When
the DNA is damaged, molecular sensors on DNA like Mre11, NBS1, and Rad 50 detect the
damage and signal to downstream proteins in the DDR cascade, ATM (Ataxia-Telangiectasia
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Mutated Protein) and ATR (ATM and RAD3-related) [6]. ATM and ATR are protein kinases that
phosphorylate downstream protein targets in response to DNA strand breaks or lesions [6]. These
protein targets include p53, CHK1/2, and p21 [6].

Figure 7: UV-Induced DNA Damage Response and Cell Pathways [6]. The goal is to maintain
genomic DNA identity. DNA damage initiates ATM/ATR proteins which signal to p53 and
CHK1/2 to either induce apoptosis, DNA repair, or cell cycle arrest.
In the DDR cascade, ATM/ATR eventually activates p53 and/or Checkpoint Kinase 1
and 2 (CHK1 and CHK2). The DDR ultimately results in three cell actions – apoptosis, DNA
repair, and cell cycle arrest [6]. Apoptosis, DNA repair, and cell cycle arrest are all essential in
maintaining genomic stability. All three will be explored in the following sections, with a
particular emphasis on proteins p21 and p53 in apoptosis and cell cycle arrest signal cascades.
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2.5.1 Apoptosis and p53 Tumor Suppressor Gene
The tumor-suppressor protein p53 is an important component of the DDR apoptosis
pathway [6]–[8]. Apoptosis, or programmed cell death, is a p53-dependent pathway and cancer
defense mechanism for damaged cells [6]. Following ATM/ATR activation by DNA damage
molecular sensors, p53 initiates BAX-mediated caspase-3 activation [6]. Caspase-3 cleaves PARP
(poly-ADP ribose polymerase) which is a marker for cell apoptosis [6]. Thus, p53 protein plays
an integral role in apoptosis.
Coined the “guardian of the genome”, p53 functions as a transcription factor that turns
genes on/off to induce cell cycle arrest and apoptosis [8]. The p53 protein is a tumor suppressor
demonstrated to influence up to 50% of all cancers [7]. In physiologically normal cells, p53 is
required for apoptosis of mutated cells before cell division. However, when p53 experiences a
loss-of-function mutation, the protein loses its ability to effectively halt DNA replication of
mutated cells [7]. Since the p53 protein is crucial in preventing tumorigenesis, a mutation in the
gene codon can be deleterious. Signature mutation hot spots commonly occur at 5’-CCG and 5’TCG sequences in codons 196, 213, 245, 248, and 282 of the p53 gene in human keratinocytes
[18].
The p53 protein is encoded by a gene located on chromosome 17 of humans [42].
However, the p53 protein needs to be activated and stabilized before it can directly activate or
repress effector genes [8]. P53 can also indirectly regulate gene transcription by binding to
transcriptional activators, repressors, and co-repressors [18]. Activation involves phosphorylation
of the p53 protein at the amino terminus by ATM, ATR, CHK1, or CHK2 in response to DNA
damage [8]. Phosphorylation prevents p53 binding with the MDM2 E3 ubiquitin-protein ligase
which normally inactivates p53 when bound (Figure 8) [8]. As demonstrated in Figure 8, the
tumor suppressor p14ARF is also responsible for activation of p53 by degrading p53-MDM2
binding [43].
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Figure 8: p53 Regulation Leading to Apoptosis and Cellular Senescence [43]. P53 increases
WAF1 and BAX leading to either apoptosis or cellular senescence.

Once activated, p53 influences gene expression by binding to specific effector genes [6],
[8], [43]. Via different pathways, p53 activation leads to both cell cycle arrest and apoptosis [6].
In terms of apoptosis, p53 functions both in the nucleus and cytoplasm via transcriptiondependent and independent methods respectively [8]. The main effector gene is PUMA, p53-upregulated modulator of apoptosis [8]. In the nucleus, p53 protein also activates BAX, which is a
member of the Bcl-2 genes that regulate apoptosis [8]. P53 additionally moves out of the nucleus
to the mitochondria, where it causes mitochondrial outer membrane permeabilization (MOMP);
the mitochondria then releases pro-apoptotic cytokines [8]
From a cell cycle arrest standpoint, p53 activates p21 (Waf1 or Cip1) which is a cyclindependent kinase inhibitor that arrests DNA replication in the G1/S checkpoint [9]. P53 can also
induce irreversible cell cycle arrest or senescence through a variety of different proteins [9]. P21
is described further in the following section. It is also important to note that p53 function is a
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highly context dependent and complicated pathway that varies based on the cell type, genome,
microenvironment, and type of cellular stress [8].
2.5.2 DNA Repair
DNA repair, in contrast to apoptosis, is a p53-independent pathway [6]. Independent of
p53, Checkpoint Kinases (CHK1/CHK2) activate BRCA2 which initiates internal cellular repair
mechanisms [6]. For humans (and other eukaryotes), the process to resolve bulky mutations like
CPDs and (6-4) photoproducts in DNA is predominantly via Nucleotide Excision Repair (NER)
[18]. NER occurs in several steps [18]. In general, the damage is recognized by DNA polymerase
and binding proteins [18]. A transcription complex of proteins binds to the damaged DNA lesion
and unwinds the strand with helicase [18]. The DNA single-strand is then removed by
endonucleases [18]. Finally, the gap is ligated and polymerized [18].
2.5.2.1 Cell Cycle Arrest and P21 Cyclin-CDK Inhibitor
Lastly, cell cycle arrest is both p53-independent and p53-dependent (Figure 7), but the
p53 dependent pathway is of interest to this thesis [6]. ATM/ATR can activate p53 which leads to
activation of p21, a cyclin-CDK inhibitor [6]. P21, also designated WAF1 or Cip1, is a protein
that induces cell cycle arrest in a p53-dependent manner [9]. Before delving into p21’s regulation
of cell cycle arrest, it is important to detail the role of the cell cycle in a physiologically normal
cell.
The purpose of the cell cycle is to duplicate the genome of a cell into identical daughter
cells during mitosis [44]. The cell cycle consists of S phase, M phase, and various gap phases
(Figure 9) [44]. During the S or synthesis phase, cells duplicate their entire genome, which
usually takes 10-12 hours on average [44]. In M phase, or mitosis, cells undergo division into two
identical daughter cells [44]. During mitosis, the replicated sister chromatids align along the
metaphase plate, separate to opposite poles of the cell, then pinch off during cytokinesis [44].
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Figure 9: Normal Cell Cycle [44]. The cell cycle consists of G1, S, G2, and Mitosis with various
checkpoints.
Separating synthesis and mitosis are G1 and G2 gap phases, which delay replication and
division to allow for cell growth [44]. During G1 and G2, cells also monitor their environment and
assess whether conditions are suitable for division [44]. The cues of intracellular proteins like p21
dictate whether the cell undergoes cell cycle arrest [44]. Within each phase is a series of
checkpoints which allow the cell to stop, check for problems in the DNA, and halt the process for
repair [44]. Cyclin-dependent Kinases (CDKs) regulate checkpoints by the binding of cyclins to
the CDK to form a functional cyclin-CDK complex [38]. CDK2, CDK4, and CDK6 are important
in interphase, while CDK1 is essential for mitosis [38].
The p21 protein plays a critical role in CDKs and cell cycle arrest. P21 is a small 165
amino acid protein that binds to CDK1 and CDK2 via a Cy1 motif in the N-terminal and Cy2 in
the C-terminal of the protein [9]. Binding disrupts the interaction between CDK and its cyclin
substrates, therefore halting the cell cycle [9]. Recent studies demonstrate that a higher expression
of p21 is associated with inactivation of genes necessary for cell cycle progression [9].
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2.6 Carcinogenesis
Skin carcinogenesis initiates when a CPD or (6-4) photoproduct lesion evades the DNA
repair process [18], [19]. The mutation is replicated, leading to a UV ‘signature mutation’ in a
gene [18], [19]. When the mutation occurs in an oncogene or tumor suppressor gene, a tumor is
likely to develop [18], [19].
Oncogene and tumor suppressor gene mutations are deleterious because they control
normal cell division, apoptosis, cell cycle repair, and DNA repair [18]–[20]. Oncogenes are
generated when normal proto-oncogenes are mutated; since proto-oncogenes regulate cell
proliferation, a mutated oncogene yields uncontrolled cell growth [18], [20]. Tumor suppressor
genes, on the other hand, slow cell division and encourage apoptosis. When a tumor suppressor
gene experiences a loss-of-function mutation, the cell evades DNA repair, slowed proliferation,
and apoptosis. The proliferation and migration of mutated cells from a pre-malignant lesion to a
primary tumor is often stepwise (Figure 10).

Figure 10: Etiology and Progression of Cancer [20]. Cancer results from repeated genetic
alterations.
Normal tissue is exposed to an environmental factor like UVB radiation and some cells
mutate. However, in order to progress from a pre-malignant lesion to tumor and metastasis,
repeated instances of genetic alterations need to occur [20]. NMSC often develops after a lifetime
of skin exposure and repeated sunburns.
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2.7 Current Prevention of UVR induced DDR
The main methods to circumvent UV damage in keratinocytes is prevention,
predominantly by protective actions [5], [12]. These protective actions include avoiding sun
during peak hours of the day, donning protective clothes like a hat and sunglasses, and applying a
broad spectrum and high Sun Protection Factor (SPF) sunscreen [12]. Sunscreen is a crucial
aspect of the photoprotection regime [5], [12]. In a 2016 poll of US dermatologists, 97% believed
that the use of sunscreen lowers the risk of skin cancer, but 99% asserted that patients generally
do not apply enough sunscreen during outdoor activities [21]. According to the Skin Cancer
Foundation, any person over the age of 6 months should apply sunscreen daily, even if indoors or
the day is cloudy [5].
Sunscreens are characterized by their Sun Protection Factor (SPF) and spectrum [5]. SPF
is a quantitative gauge for the UVB protective ability. SPF 15, 30, and 50 filter 93%, 97%, and
98% of UVB rays respectively [5]. A broad-spectrum sunscreen contains chemical and physical
filters to protect skin from both UVA and UVB radiation. The Skin Cancer Foundation
recommends applying about 1 oz (a full shot glass) of sunscreen to receive the advertised SPF
and spectrum benefits; however, most users only apply half the recommended dose to their skin
[5]. Furthermore, sunscreen should be applied 30 minutes before sun exposure, and reapplied
every 2 hours and following water contact or sweating because they lose efficacy over time [5].
Most Americans do not use sunscreen as recommended.
2.7.1 Sunscreen Active Ingredients and Limitations
Sunscreen protects skin via chemical and physical means which decrease UVA and UVB
penetration into the epidermis and dermis [5]. Chemical ingredients (e.g. oxybenzone,
avobenzone, octisalate, octocrylene) absorb UV radiation, while physical ingredients (e.g. zinc
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oxide, titanium dioxide) deflect UV rays [5]. A conventional sunscreen combines both chemical
and physical filters.
Although the Food and Drug Administration (FDA) has currently approved over 15
sunscreen ingredients, some chemicals have received conflicting reports as to their safety and
efficacy [10]–[12]. One such ingredient is the organic chemical filter oxybenzone
(benzophenone-3). Oxybenzone provides broad spectrum protection by absorbing and quickly
dissipating the UV energy by breaking chemical bonds [45].
Studies have demonstrated that oxybenzone causes allergic skin reactions, disrupts
endocrine function, and pollutes the environment [10], [12]. In a 10-year study between 2001 and
2010, 70.2% of approximately 24,000 patients exhibited dermatologic allergies to oxybenzone
when patch tested [12]. In addition, a 2001 study conducted by Schlumpf et al. asserted that 21day-old rats fed doses of oxybenzone in their feed experienced hormone disruption [10], [12].
However, the dosage fed to the animal subjects were not physiologically relevant to the human.
For example, it would take 277 years to reach the systemic concentration of oxybenzone in the rat
study for a human applying a 6% oxybenzone FDA approved sunscreen at 2 mg/cm2
concentration [11]. Although different studies dispute the degree to which oxybenzone is
cytotoxic in humans, given the prevalence of skin cancer, the need for more natural alternatives is
important.
2.8 Sphingomyelin as a Natural Alternative to Sunscreen
Sphingomyelin (SM), a natural phospholipid, has demonstrated potential as a
chemoprotective agent. Dietary administration of bovine milk sphingomyelin in mice reduced the
formation and number of colon tumors [22]. Orally administered bovine milk SM was found to
incorporate into the stratum corneum [23]. Additionally, the dietary SM that localized in the skin
reduced Transepidermal Water Loss (TEWL) and increased the water content of skin after UVB
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radiation [37]. Lab research on KRT monolayers by De Guzman and Campbell et al. have also
demonstrated promising results for SM photoprotection [13], [14]. Before exploring past
research, a general overview of lipids, SM, and metabolite roles in the DDR is necessary.
2.9 Sphingolipids
In general, lipids are organic compounds insoluble in water but soluble in organic solvents
[46]. According to LIPID Metabolites and Pathways Strategy (LIPID MAPS®) database, there
are eight main lipid classifications: fatty acyls, glycerolipids, slycerophospholipids, sterol lipids,
saccharolipids, prenol lipids, polyketides, and sphingolipids [46]. Because of the complex
structural nature of lipids, classification can be subjective, and the LIPID MAPS database
categorizes lipids based on their chemically functional backbone in an effort to make organization
more universal [46]. Two lipids that play integral roles in cell signaling and the DNA damage
response are sphingomyelin and ceramide, both classified under the sphingolipids branch and
often described as bioactive because they modulate cell signaling and function [46].
Sphingolipids are important cellular components, representing 10-20% of all cellular lipids [47].
Figure 11 depicts the structure of sphingomyelin and its common metabolites: ceramide,
sphingosine, and sphingosine-1-phosphate [48]. More information regarding the structure and
function is detailed in subsequent sections.
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Figure 11: General Chemical Structures for Sphingomyelin, Ceramide, Sphingosine, and
Sphingosine-1-Phosphate [48]. (A) Sphingomyelin, (B) Ceramide, (C) Sphingosine, (D)
Sphingosine-1-Phosphate (S1P).

Sphingolipids regulate numerous biological functions and properties. For example, SM
has been shown to influence the properties of the plasma membrane (fluidity, thickness and
curvature) by closely associating with cholesterol and other sterols in lipid raft microdomains
[47]. Subsequent cell signaling and protein sorting are influenced by membrane composition [47].
As previously described, SM also affects skin Transepidermal Water Loss (TEWL) [16]. Finally,
SM is a precursor of bioactive lipid metabolites including ceramide and sphingosine-1-phosphate
which mediate apoptosis, p21, and p53 levels after UV damage through cellular targets [6], [47].
Cells sense perturbations in lipid levels by soluble and transmembrane proteins that modulate
sphingolipid metabolism [47]. Imaginably, maintaining lipid homeostasis is of utmost importance
for the cell in order to ensure proper cell function and phenotype [49]. For example, Neiman
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Picks, Tay-Sachs, Gaucher’s, and Farber’s disease result from deficient lipid homeostasis
mechanisms [47], [49], [50]. The following sections highlight sphingomyelin and ceramide, with
a particular emphasis on ceramide due to its implications in UV damage, apoptosis, p21, and p53
[6], [47].
2.10 Sphingomyelin and Ceramide Metabolism
Sphingomyelin (SM) is a complex phospholipid composed of a phosphorylcholine head
and two nonpolar hydrocarbon chains of varying lengths (Figure 11A) [48]. SM is naturally
present, in low levels, on the outer leaflet of the plasma membrane associated with cholesterol in
lipid raft domains [49], [51]. SM is also generated intracellularly by the modification of ceramide
by SM synthase in the Golgi body, then it is trafficked to the plasma membrane [27]. SM
degradation is also a fundamental homeostasis mechanism. In the plasma membrane and
endosomes/lysosomes, aSMase and nSMase cleave sphingomyelin into ceramide [6], [27].
Ceramide then influences downstream cellular processes [6].
Ceramide is the hydrophobic backbone of complex sphingolipids including
sphingomyelin, cerebrosides, and gangliosides (Figure 11) [52]. The structure of ceramide is a
variable chain length fatty acyl bound to a sphingosine backbone [52]. The fatty acid bonds are
generally saturated or monosaturated. Ceramides with chain lengths C16-24 are most common in
mammalian cells, however, C26-C36 are present in some epidermal keratinocytes undergoing
differentiation [52]. In addition, ceramide structures differ depending on the location of a hydroxy
(-OH) group. Ceramides with an -OH functional group bound to the second carbon (C2) in the
variable chain length are termed alpha-hydroxy fatty acids, and ceramides with -OH bound to the
last carbon are appropriately termed omega-hydroxy fatty acids [52]. Because of their chemical
structure, ceramides are highly hydrophobic (water-repellent) and exhibit low polarity and
insolubility in water [52].
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Ceramide metabolism is responsible for cell signaling which in turn regulates a myriad of
cell responses including proliferation, apoptosis (programmed cell death), and cell senescence [6].
Lipid metabolism is a multi-faceted process with numerous sphingolipids that orchestrate cellular
processes [6]. The focus of this thesis will be on the ceramide-sphingomyelin link, and the
enzymes, proteins, and cellular machinery that regulate degradation and catabolism of these
bioactive lipids. The generation, metabolism, and even location of ceramide in a cell is important
for mediating cellular response [6], [27], [53].

Figure 12: Pathways of Ceramide Generation and Metabolism [53]. Pathway 1 represents de
novo synthesis, pathways labeled 2 are complex sphingolipid hydrolysis to ceramide, and
pathway 3 is the salvage pathway.
In the study of ceramide, it is useful to separate metabolic activities into pathways that
result in the modification of ceramide (either through metabolism into simpler products or as a
building block for more complex sphingolipids) and pathways that form ceramide (Figure 12)
[53]. Ceramide is generated through three independent pathways, each involving different
enzymes (Figure 12) [53]. The first pathway is de novo synthesis. The de novo pathway occurs in
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the Endoplasmic Reticulum (ER) and starts with serine and palmitoyl CoA [6], [52], [53]. Serine
and palmitoyl CoA are condensed to 3-keto-dihydrosphingosine by the enzyme serine
palmitoyltransferase (SPT) [6], [52], [53]. Next, 3-keto-dihydrosphingosine is broken down to
dihydrosphingosine (sphinganine) then further reduced to dihydroceramide by ceramide synthase
(CERS) [6], [52], [53]. CERS is present in six different isoforms which have an affinity for
different acyl CoA backbone lengths [6]. Finally, dihydroceramide is converted to ceramide by
dihydroceramide desaturase (DEGS) [6], [52], [53]. After de novo ceramide formation in the ER,
ceramide is trafficked to the Golgi by the Ceramide Transfer Protein (CERT) where it is further
processed [52].
The second mechanism for ceramide generation involves hydrolysis of the complex
sphingolipids SM and glucosylceramide [6], [52], [53]. Of interest for this thesis is the hydrolysis
of SM to ceramide, which occurs in the plasma membrane and to some extent in the
endosomes/lysosomes circulating in the cytosol of cells. The enzyme sphingomyelinase (SMase)
degrades sphingomyelin to ceramide and a free phosphcholine head [6]. Three different SMase
enzymes exist and vary based on the pH of the target location [6], [52], [53]. In the plasma
membrane, both neutral SMase (nSMase) and acidic SMase (aSMase) are present to hydrolyze
SM to ceramide [6]. In the endosomes/lysosomes of cells, aSMase is mainly responsible for the
hydrolysis [6]. Lastly, alkaline SMase (alkSMase) is found in the digestive tract and remains the
least characterized SM enzyme [6].
The third mechanism, the Salvage Pathway, involves the recycling of sphingosine from
sphingosine-1-phosphate (S1P) by S1P Phosphatase in the lysosome and endosomes of cells [54].
S1P accumulates after sphingosine phosphorylation by Sphingosine Kinases and is a vital
bioactive lipid implicated to cancer [6]. Figure 13 includes a summary representation of
sphingolipid metabolites and relative locations in either the plasma membrane, Golgi,
endoplasmic reticulum, and endosomes/lysosmes [27].
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Ceramide degradation mainly occurs with acidic/neutral ceramidases which break down
ceramide to sphingosine (Figure 13). Like ceramide generation via SMases, ceramide degradation
by ceramidases occurs in the plasma membrane and endosomes/lysosomes of cells [6], [27]. The
eventual byproducts of ceramide catabolism in the plasma membrane are sphingosine and S1P
[6], [27]. In the Golgi of a cell, ceramide is modified by SM synthase to form sphingomyelin [6],
[27]. Lastly, ceramide present in the ER can be degraded to sphingosine (and eventually S1P) by
alkaline ceramidases [27].

Figure 13: Summary of Sphingolipid Metabolism and Location in a Cell [27]. Ceramide is
metabolized to sphingomyelin and S1P in different cellular locations.

2.11 Sphingolipids, DDR Cascade, and Carcinogenesis
Phospholipids metabolites can have either pro-survival or pro-apoptotic effects, and the
regulation of enzymatic metabolism is key to determining which sphingolipids are produced, and
their effect on UV-irradiated skin cells [6], [55]. Various bioactive metabolites are responsible for
initiating the DDR including ceramide (Cer), sphingosine, and sphingosine 1-phosphate (S1P)
[6]. Ceramide is one of the central hubs of the DDR and regulates cell death by inducing a proapoptotic cellular phenotype [6], [55].
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Ceramide apoptotic mechanisms originate by the targeting of CAPPs (ceramide-activated
Ser-Thr protein phosphatases), enzymes that remove phosphate groups from proteins [55]. One
such CAPP is PP2A (protein phosphatase 2A) which inactivates the anti-apoptotic kinase AKT
(serine/threonine-specific protein kinase) also known as protein kinase B and upregulates
expression of p53 (Figure 14) [55]. Ceramide also activates PKC (Protein Kinase C)-zeta which
downregulates AKT [55]. In addition, ceramide signals to ASK1 (Apoptosis Signal-regulating
Kinase 1) and upregulates pro-apoptotic JNK, p38, and BAX levels [55]. Furthermore, prosurvival BCL-2 is downregulated [55]. These pathways eventually cause MOMP (Mitochondrial
Outer Membrane Permeabilization) and release of the apoptotic protein cytochrome C and
caspases [54]–[56]. Cathepsin D protein also enables apoptosis, in a mitochondria-independent
manner [55].

Figure 14: Ceramide Mechanisms for Cellular Apoptosis [55]. Ceramide and S1P mediate
contradictory cell functions.
Figure 14 also demonstrates the importance of S1P, which has contradictory functions
compared to ceramide [6], [55]. Ceramide, a pro-apoptotic lipid, and S1P, a pro-survival lipid,
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form a hypothetical ‘rheostat’ or ‘scale’ that can be tipped towards either apoptosis or cell
survival depending on the type and amount of lipid available in a cell [6], [55]. Thus, the lipid
metabolite produced in a cell greatly affects cell fate [6]. For example, in cancer cells, the prosurvival genes for S1P are upregulated, and in turn, the pro-apoptotic genes for ceramide
production are downregulated [53]. In addition, accumulation of ceramide is linked to more
cellular apoptosis as a protection mechanism for damaged cells [6], [53], [55]. Current anti-cancer
treatments point to the apoptotic and tumor suppressive nature of ceramide [55]. Therefore,
common treatments either introduce exogenous ceramide supplements to encourage cellular
apoptosis, or inhibit ceramide metabolism [55]. The ceramide-S1P rheostat and complexity of
lipid metabolism necessitate further research into mechanisms, homeostasis, and potential
treatments for UV-induced DDR and cancer.
2.12 Bovine Milk Sphingomyelin Past Research and Limitations
Bovine milk SM has demonstrated significant potential as an anti-cancer treatment in the
colons of mice [22]. In addition, oral consumption of SM in a mouse model demonstrated SM
accumulation in the skin and a decreased skin TEWL after UVB [16], [37]. Previous work by De
Guzman and Campbell from the Cal Poly Bioimaging Lab suggested bovine milk SM
photoprotection for a monolayer of KRTs [13], [14]. P21 and p53 levels statistically decreased in
SM-treated cells after UVB radiation compared to the control without SM [13], [14]. The results
suggested photoprotective effects of bovine milk SM on KRT monolayers after UVB radiation.
However, these past studies were limited in that the mechanism of action for bovine milk
SM photoprotection was not addressed. Direct visualization of intracellular FSM distribution by
fluorescence for various conditions is necessary as a way to address this limitation. In addition,
the cell model was a 2D monolayer, and moving to a third dimension could prove more
physiologically relevant.
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2.13 Probing In Vitro Lipid Dynamics with Fluorescence
In order to validate the mechanisms occurring in a cell, it is important to study lipid
dynamics in vitro. Imaging proves to be a valuable method for assessing lipid distribution in a
cell and provides more spatial information than High Performance Thin Layer Chromatography
(HPTLC) and associated methods [57]. However, tracking intracellular distribution of bovine
milk SM is difficult because the phospholipid is not fluorescent under normal conditions.
Fluorescently tagged sphingomyelin has come to the forefront of lipid research, with multiple
research groups developing novel methods to identify SM for intracellular trafficking studies and
metabolism with imaging [58]–[60].
C6- NBD Sphingomyelin (abbreviated FSM in this thesis), manufactured by Avanti Polar
Lipids, is one such example (Figure 15). The chemical structure differs from their bovine milk
chemical by the addition of a fluorescent tag, indicated by the dashed box [61]. Despite the NBD
attachment, FSM proves to be a sufficient analogue because its compact shape limits functional
disturbance of in vivo processes [62].

Figure 15: Avanti Polar Lipid Diagrams of Molecules [61].
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Koval and Pagano et al. led first efforts to characterize FSM in Chinese Hamster Ovary
(CHO) cells. Plasma membrane staining followed by rapid entry and Golgi accumulation was
observed [60]. FSM was introduced (pulsed) to cells at 370C, back-exchanged with BSA on ice to
remove residual FSM outside the cell plasma membrane, then chased with a 370C media
exchange to assess FSM trafficking [60]. Koval and Pagano’s research was also repeated by other
groups including Hao et al. and Kok et al. [58], [59]. FSM internalization was found to be
temperature-dependent and trafficking rate declined at lower temperatures [58], [59]. Exogeneous
administration of FSM was determined to be internalized by endocytosis into vesicles and
recycled by three main mechanisms: 1) Rapid recycling from endosomes to the plasma
membrane, 2) endosome to lysosomes for degradation to downstream metabolites, 3) endosomes
to Golgi [63].
A novel probe called Lysenin has recently been developed for fluorescence detection of
endogenous cellular SM [64]. Lysenin is a 41-kDa protein obtained from purified coelomic fluid
of the earthworm Eisenia foetida [64]. This protein binds selectively to SM, as demonstrated by
ELISA, TLC, and other methods [64]. Mound et al. used lysenin, in conjunction with FSM, to
visualize lipid raft organization in the plasma membrane of KRTs [65]. Colocalization of lysenin
with FSM signal was quantified, and Mound demonstrated that lysenin signal diminished after the
addition of SMase, an enzyme that degrades SM [65]. The signal obtained was predominantly
concentrated around the plasma membrane [65]. The heterogeneity of lysenin staining was also
described and the overall signal declined as the cells reached senescence [65].
Although published research predominantly uses an exogenous version of ceramide or
lysenin with a direct fluorescent tag, immunofluorescence assays have also been developed for
both lysenin and ceramide [64], [66]. For endogenous SM staining, lysenin is first bound to SM,
then an anti-lysenin primary antibody is introduced followed by secondary fluorescent tag [64].
Ceramide immunofluorescence also involves an antibody against ceramide and a secondary
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fluorescent tag [66]. Optimization of each step in the staining procedure was necessary to obtain a
quality signal. Both lysenin and ceramide antibodies prove useful for colocalization experiments
and probing lipid trafficking in a cell.
2.14 Tissue Engineered 3D Skin Culture
Tissue engineering is a field of regenerative medicine aimed at creating accurate in vitro
models to mimic the in vivo characteristics of human tissue [67]. This field traditionally combines
cells, a biomaterial scaffold, and growth factors or other chemical/external stimuli to guide cell
proliferation into a structure that better recapitulates tissue [67]. From a tissue engineering
standpoint, a 3D model proves potentially more advantageous over previously described KRT 2D
monolayer studies because multiple layers of cells can be grown and studied [13], [14]. The
many layers of stratified KRTs in vivo can be mimicked in vitro. Developing tissue engineered
skin for assessing BSM and FSM photoprotection after UV is a scientifically advantageous goal
to progress research in this field [13], [14].
Based on a 2017 review of current tissue engineered skin technologies, most in vitro skin
models resemble a flat sheet, with keratinocytes and/or fibroblasts cultured on top a natural
and/or synthetic biomaterial scaffold (Figure 16) [68]. For example, ApligrafTM combines
keratinocytes with fibroblasts and collagen to recreate both the epidermis and dermis [68]
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Figure 16: Review of Current Tissue Engineering Skin Products [68].
Despite the success of many sheet-based tissue engineering products for skin, some
limitations exist mainly involving time and cost [68]. For example, according to Vig et al., most
skin products require 2-3 weeks of culture time and significant lab resources; for example,
approximately $13,000 of lab resources are needed to produce enough of EpicelTM skin to cover
1% of the body’s surface area [68]. Given the limitation of current techniques, research into more
efficient 3D culture methods is important.
3D spheroids have recently risen to the forefront of research, mainly involving tumor
cancer biology, brain organoids, angiogenesis sprouting, and drug testing applications [69]–[77].
Spheroids are essentially aggregates of cells stimulated to form 3D structures by a variety of
culture methods including hanging drop, non-adhesive surfaces, spinner flask, and microcarrier
beads (Figure 17) [77]. Spheroids have demonstrated success with numerous peer-reviewed
papers [69]–[77]. Additionally, a number of groups have utilized the non-adherent culture
conditions, with either low adherence 96-well culture plates or 1% agarose coating of flat-bottom
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wells [71]–[74]. Cells at an optimized seeding density were combined with methylcellulose (1520% diluted in media) and seeded into non-adherent conditions [72], [73]. Methylcellulose
functions as a binding agent to provide a high viscosity environment for optimal spheroid
compaction [78]. After a week of culture, mature spheroids usually form and are ready for
assessment [72], [73]. In addition, mixed culture spheroids are possible, with one group utilizing
three cell types to form blood brain barrier spheroid organoids [70]. Spheroids were commonly
assessed via immunostaining and fluorescence microscopy or histological embedding and
sectioning [69]–[77]. Additionally, spheroids can be iteratively optimized by varying seeding
density, methylcellulose concentration, culture time, and co-culture conditions among other
variables. Given the relatively time-efficient protocols, reduced use of lab resources, and control
over culture parameters, spheroids prove useful for investigation into skin applications.

Figure 17: Methods of 3D Spheroid Formation [77].
Due to the historical success of sheet-based skin models (Figure 16), few research groups
have developed skin spheroids [79], [80]. Some research groups have found success combining
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KRTs with dermal fibroblasts in a dual culture system [79]. Furthermore, Syntivia, a French
biotechnology company, developed a skin model for in vitro cosmetic testing [80]. Following
patent publication in August 2017, Syntivia created an epidermal keratinocyte-melanocyte coculture spheroid in Matrigel [80]. Their patent pointed to the highly optimized process and coculture method required for skin to stratify in a 3D spheroid structure [80]. Despite Syntivia’s
success, their Matrigel scaffold is limited in that the constituent proteins are highly
uncharacterized, derived from mouse sarcoma (a xenograph and potentially immune eliciting
substance), and varies significantly between product lots and batches [81]. Further research into a
consistent skin cell spheroid model is warranted to determine if the model is physiologically
relevant to previous 2D monolayer studies and gold standard sheet-based constructs.
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2.15 Overview and scope of thesis
Past research in the lab involving bovine milk SM and the p21 damage marker has
demonstrated a photoprotective promise for SM. However, previous cell monolayer research has
failed to demonstrate the mechanism of action for protection, link FSM with UVB, and
recapitulate the 3D environment of skin. Thus, the goals of this thesis were three-fold and
attempted to answer the following research question goals, each divided into separate subsets.
1.) Goal 1: Does FSM intracellular trafficking change with varying incubation times, and
after UVB radiation?
a. Subset 1: Characterize FSM in KRT culture during live and fixed cell cultures
using fluorescence confocal imaging
b. Subset 2: Assess the localization of FSM in normal and UVB-stressed KRTs
under varying incubation times
c. Subset 3: Demonstrate functional equivalence of bovine milk SM to its
fluorescent counterpart
2.) Goal 2: Do endogenous SM and ceramide levels fluctuate with exogenous FSM
incubations? Is it possible to characterize, with fluorescence microscopy, the identity of
the observed FSM signal over time?
a. Subset 1: Develop immunofluorescence staining protocols for both endogenous
SM (lysenin) and endogenous ceramide
b. Subset 2: Characterize how endogenous SM and ceramide levels change with
varying FSM incubation timepoints
3.) Goal 3: Are cell spheroids a viable platform to move future research from a 2D to 3D
model?
a. Subset 1: Develop a method to culture NIH 3T3 immortalized mouse fibroblast
spheroids, for eventual incorporation of KRT cells and FSM
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b. Subset 2: Quantify dye penetration over various concentrations and incubation
times
First, FSM was characterized in our model system of KRTs. A p21 immunofluorescence
stain was employed as a substantial equivalence test to compare photoprotective benefits of FSM
and bovine milk SM. The location and brightness of the stain was tracked both in live and 3.75%
paraformaldehyde (PFA) fixed cells using confocal microscopy. The main purpose of localization
quantification was to assess where the FSM stain is trafficked, and if fluorescence localization is
perturbed with UVB exposure. Trafficking is valuable because different lipid metabolic processes
occur in various cellular locations [27].
It was hypothesized that total intracellular FSM levels would initially increase when
added to the cells, then decrease with hydrolysis to ceramide and exocytic recycling mechanisms.
With UV exposure, the FSM levels would diminish further because UV would stimulate the
hydrolysis mechanism and increase levels of ceramide. Enhanced intracellular ceramide would
then increase apoptosis levels in a cell, contributing to FSM photoprotection.
Second, immunofluorescence staining protocols were developed for both endogenous SM
(lysenin) and endogenous ceramide. The goal of incorporating these two stains was to assess,
both qualitatively and quantitively, the location of endogenous SM and ceramide in a cell and if
introduction of exogenous FSM disturbed lipid dynamics. Although not completed in this thesis,
lysenin and ceramide stains could eventually be used to assess the fluctuations in localization and
signal brightness after UVB exposure. Another future goal for immunostaining is to better
characterize FSM by developing a repeatable and quantifiable fluorescence colocalization method
for FSM, lysenin, and ceramide. As FSM is introduced and metabolized, it is unknown whether
the fluorescence probe remains attached to a downstream metabolite (not a true sphingomyelin)
or if the probe is cleaved and exocytosed from the cell. Measuring colocalization of lysenin with
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FSM and ceramide with FSM provide first steps towards understanding the degradation of the
fluorescent probe attached to FSM.
Finally, the third main goal was to develop a culture method for 3D spheroids using 3T3
cells. The nuclei of 3T3 spheroids were stained and imaged on the confocal microscope to assess
dye penetration depth. The methods developed can be used to culture KRT-3T3 dual spheroids
and quantify the effects of FSM incubation on a 3D culture system.
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3. METHODS
3.1 Keratinocyte Cell Culture
Primary Epidermal Keratinocytes (KRTs), Normal, Human, Neonatal Foreskin (HEKn,
PCS-200-010, ATCC Manassas, VA) were cultured using aseptic technique in a 370C, 5% CO2
incubator prior to experiments. KRT media was made following ATCC guidelines by combining
one Keratinocyte Growth Kit (PCS-200-040, ATCC, Manassas, VA) with one bottle of Dermal
Cell Basal Medium (PCS-200-030, ATCC, Manassas, VA), and 0.5 mL of PenicillinStreptomycin-Amphotericin (PCS-999-002, ATCC, Manassas, VA). The mixture was then sterile
filtered with a 0.22µm filter. KRTs were expanded in canted T-75 Falcon from Corning Tissue
Culture Flasks (BD353136, VWR, Visalia, CA) and passaged at approximately 70% confluence
into 8-well Nunc Lab-Tek Chambered Coverglasses from Thermo Scientific (43300-774, VWR,
Visalia, CA) for experiments. The 8-well plates were mounted on No. 1 borosilicate glass and
allowed for inverted confocal imaging. During culture, the monolayer of cell was visually
assessed via brightfield microscopy every 24-48 hours and media was exchanged every 48 hours.
3.2 Sphingomyelin Treatment – BSM and FSM
Bovine Milk SM or BSM (860063P-25mg, Avanti Polar Lipids, Alabaster, AL) was
obtained in powdered form. The BSM was weighed and added to KRT media to create a 0.1%
BSM solution. The powder was mixed in the media via sonication and vortexing to create a
homogenous solution. The solution was finally passed through a 0.22µm filter to sterilize then
stored in the refrigerator. The BSM solution was discarded on the expiration date of the media.
Fluorescent SM or C6-NBD Sphingomyelin (810218P-1mg, Avanti Polar Lipids,
Alabaster, AL) was also acquired in powdered form then dissolved in ethanol to yield a 1mM
stock solution. The stock was stored at -200C in a tightly sealed glass container protected from
light until further use. To make the FSM media treatment administered to cells, an appropriate
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volume of ethanol-FSM stock was added to a 5uM Bovine Serum Albumin diluted in KRT media
to yield a 5uM FSM final concentration.
When KRTs in the 8-well plates reached 70% confluence, approximately 200µL of SM
treatment was added to each well. Cells were incubated for various times with the SM prior to
UV radiation.
3.3 UVB Irradiation
UVB radiation (302 nm) at a dose of 40 mJ/cm2 was administered to the cells in a twostep process. First, the average intensity of the UV lamp (95-0251-01, UVP, LLC, Upland, CA)
was measured with a UV sensor (S120UV, ThorLabs, Newton, NJ) and connected power meter
(PM100, ThorLabs, Newton, NJ). Figure 18 provides a visual representation of the UV lamp
calibration and treatment administration under aseptic technique. All equipment was sprayed with
70% Isopropyl Alcohol (IPA) prior to use in the culture hood.

A

B

Figure 18: UVB Radiation. (A) Calibration of Lamp, sensor (white arrow), power meter (red
arrow), ABS plastic tray (green arrow). The white UV lamp is shown atop the black containment
box. The exposure time was calculated based on the desired dose and average intensity of the
lamp. (B) UV calibration and treatment to cells were conducted inside the culture hood after
spraying all equipment down with 70% IPA. The cells were placed on the blue plastic tray and
slid under the UV box/lamp. Spent media was replaced prior to UV.
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The exposure time of cells to UV required for the radiation dosage was calculated using
the following equation [13]. The measured irradiance was calculated by determining the average
intensity of the UV sensor during calibration, and dividing by the sensor area of 0.7088cm2 [13].
The prescribed dose is equal to 40 mJ/cm2. The exposure time is roughly 60 seconds.

Exposure Time (seconds) =

mJ
Prescribed Dose ( 2 )
cm

1mW
μW
(1000μW) ∗ Measured Irradiance ( 2 )
cm

The UV lamp was housed in UV box constructed of Delrin plastic which contained the
radiation and protected the user. The Acrylonitrile Butadiene Styrene (ABS) plastic tray was 3D
printed to hold the sensor and 8-well culture plate, and ensure the system remains directly under
the UV radiation source (green arrow Figure 18).
The second step of the UV process was direct administration to the cells. KRTs in 8-well
plates were removed from the incubator and the spent media (or SM solutions) were aspirated and
replaced with 200µL of fresh KRT media. The plates were placed on top of the tray, slid under
the UV lamp, and exposed to UV for the calculated time (based on the dose and irradiance). After
UV, cells were placed back in the incubator and visually assessed for signs of contamination.
Figure 19 provides an example plate layout used for SM and UV treatment.

UV

SM (+)

SM (-)

SM (-)

SM (+)

SM (+)

SM (-)

SM (-)

SM (+)

Figure 19: Typical Plate Distribution for SM and UV Treatments. SM was administered in a
diagonal pattern with (+) meaning the presence of SM and (-) denoting the absence of SM. The
entire plate was subjected to UV, as indicated by the lightning bolt.
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SM was directly added to wells in a diagonal pattern, and the entire plate was UV’ed. The
diagonal pattern randomized the treatment locations and reduced bias introduced by positiondependent fluctuations in UV intensity.
3.4 Cell Fixation and Staining
After UV exposure, cells were fixed in 3.7% paraformaldehyde (PFA). The time after UV
was dependent on the experimental treatment. The media was gently removed from the wells, and
one wash was performed with a 1X Phosphate Buffer Solution (PBS). 200µL of PFA was
pipetted in each well, and the plate was incubated for 15 minutes at room temperature. After
fixation, cells were washed three times with PBS. After fixation, cells were subjected to various
immunostaining protocols depending on the experimental objective.
3.4.1 p21
The p21 indirect immunostaining protocol was previously optimized by the lab [13].
Following BSM or FSM incubation and UV exposure, p21 immunostaining was conducted
according to established protocol shown in Table I.

45

Table I: p21 Immunostaining Protocol [13]
Protocol Step
Fixation

Reagent
Paraformaldehyde

Concentration
3.7%

Exposure
15 min

Permeabilization
Blocking

Trixon X-100
10% Normal Goat
Serum
Anti-p21 antibody
(rabbit)
AF 647 (goat,
anti-rabbit)
Hoechst 34580

0.1%
1%
1:400

20 min
Overnight
(~12 hrs)
9 Hours

1:400

1 hour

0.03%

15 min

Primary
Secondary
Nuclear Staining

Vendor Information
Electron Microscopy
Solutions (RT 15710)
Invitrogen HFH10
Life Technologies
500622
Abcam ab18209
ThermoFisher
Scientific A-11008
Life Technologies
H21486

The monolayer of each well was exposed to 200µL of 0.1% TritonX-100 diluted in PBS
for 20 minutes to permeabilize the cell membrane and allow antibody entry into the nucleus.
200µL of a blocking solution, 10% goat serum diluted in PBS, was administered and allowed to
incubate overnight at 40C. The blocking solution reduced non-specific binding of the primary and
secondary while reducing image noise and enhancing signal to noise ratio. The next day, 200µL
of 1:400 p21 antibody (raised in rabbit) diluted in PBS was added and incubated for 9 hours at
40C. Next, 200µL of 1:400 goat, anti-rabbit AF 647 secondary diluted in PBS was administered
for 1 hour. Finally, a Hoechst 34580 stain, 0.03% diluted in PBS was added to the well for 15
minutes. Between each step in the process, the previous reagent was washed off 3 times with
PBS. Care was taken to gently administer the liquid treatments to each well in order to prevent
washing off of cells.
3.4.2 Lysenin
In order to visualize endogenous sphingomyelin in a cell, indirect immunostaining was
conducted. The protein Lysenin was used to bind on to sphingomyelin, then an anti-Lysenin
antibody and secondary were introduced to fluorescently tag the lysenin (Table II)
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Table II: Lysenin Immunostaining Protocol
Protocol Step
Fixation

Reagent
Paraformaldehyde

Concentration
3.7%

Exposure
15 min

Permeabilization
Blocking

Trixon X-100
BSA
10% Normal Goat
Serum

0.1%
4%/4%

20 min
Overnight
(~12 hrs)

Protein
Attachment to
SM
Primary

Lysenin from
Eisenia foetida

1µg/mL

2 hours

Anti-Lysenin pAb
(rabbit)
AF 594 (goat, antirabbit)
Hoechst 34580

1:1000

1 hour

1:300

1 hour

0.03%

15 min

Secondary
Nuclear Staining

Vendor Information
Electron Microscopy
Solutions (RT 15710)
Invitrogen HFH10
Spectrum Chemicals
AL 135
Life Technologies
500622
Millipore Sigma
L3038
Creative Diagnostics
DPAB214905
ThermoFisher
Scientific A11012
Life Technologies
H21486

After fixation and permeabilization, the cells were blocked overnight at 40C with 4%
BSA and 4% Goat Serum solution, abbreviated 4%BSA/4%Goat, diluted in PBS. This blocking
solution was optimized specifically for lysenin and dual staining with ceramide to prevent nonspecific primary and secondary binding. Tween-20 was temporally tested in the blocking buffer
to further reduce non-specific primary binding, but it was ultimately removed when the FSM
signal was washed out.
Lysenin from Eisenia foetida (L3038-50UG, Millipore Sigma, St. Louis, MO) was
purchased in powder form and reconstituted in 2% BSA in PBS to make a 10µg/mL stock.
Unused stock was aliquoted and stored at -200C. The lysenin was further diluted in PBS and
incubated with cells at a 1µg/mL optimized concentration for 2 hours at room temperature. Next,
a rabbit anti-lysenin polyclonal antibody (DPAB214905, Creative Diagnostics, Shirley, NY) was
diluted 1/1000 in blocking solution and incubated for 1 hour at room temperature. The secondary
AF594 Goat Anti-Rabbit (A11012, ThermoFisher Scientific, Waltham, MA) was diluted 1:300 in
PBS and incubated for 1 hour at room temperature. Lastly, the nucleus was stained with 0.03%
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concentration of Hoechst 34580 for 15 minutes at room temperature. Between each protocol step,
the previous reagent was washed three times with PBS.
3.4.3 Ceramide
An indirect immunofluorescence staining assay was utilized to fluorescently visualize
ceramide in a cell. Table III details the list of reagents and optimized staining procedure. After
fixation and permeabilization, the cells were blocked overnight at 40C with 4% BSA and 4% Goat
Serum solution, abbreviated 4%BSA/4%Goat, diluted in PBS. A mouse anti-ceramide
monoclonal antibody (C8104, Millipore Sigma, St. Louis, MO) was diluted 1/400 in blocking
solution and incubated for 9 hours at 40C. The secondary AF 647 Goat Anti-Mouse (A21235,
ThermoFisher Scientific, Waltham, MA) was diluted 1:300 in PBS and incubated for 1 hour at
room temperature. Lastly, the nucleus was stained with 0.03% concentration of Hoechst 34580
for 15 minutes at room temperature. Between each protocol step, the previous reagent was
washed three times with PBS.
Table III: Ceramide Immunostaining Protocol
Protocol Step
Fixation

Reagent
Paraformaldehyde

Permeabilization
Blocking

Trixon X-100
BSA
10% Normal Goat
Serum

0.1%
4%/4%

20 min
Overnight
(~12 hrs)

Primary

Anti-Ceramide
mAb (mouse)
AF 647 (goat, antimouse)
Hoechst 34580

1:400

9 hours

1:300

1 hour

0.03%

15 min

Secondary
Nuclear Staining

Concentration Exposure
3.7%
15 min
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Vendor Information
Electron Microscopy
Solutions (RT 15710)
Invitrogen HFH10
Spectrum Chemicals
AL 135
Life Technologies
500622
Millipore Sigma
C8104
ThermoFisher
Scientific A21235
Life Technologies
H21486

3.4.4 Dual Staining
Cells were co-stained for both lysenin and ceramide. Cells were fixed and permeabilized,
followed by overnight blocking at 40C with 4% BSA/4% Goat diluted in PBS. Next, the lysenin
protein then subsequent lysenin antibody were introduced to the cells according to established
protocol. Then the ceramide antibody was incubated for 9 hours, followed by simultaneous
secondary incubations (AF 647 goat anti-mouse and AF 594 goat anti-rabbit) diluted in PBS and
introduced at the same time at their respective concentrations. Finally, the nuclei were stained
with Hoechst. Sufficient washing steps were performed between each step in the protocol.
3.4.5 Nile Red
Nile Red powder (N3013-100MG, Millipore Sigma, St. Louis, MO) was reconstituted in
methanol to from a 1mg/mL stock concentration which was stored long-term at 200C. The stock
was further dissolved in PBS to make a 5µM/mL solution. Cells were exposed to Nile red for 15
minutes than washed three times with PBS prior to imaging.
3.5 Spheroid Cultivation, Staining, and Manipulation
Spheroids were formed by adding NIH-3T3 cells to methylcellulose binding agent. The
cells plus methylcellulose were seeded into non-adherent U-well plates and cultured for 3-5 days
prior to cultivation, staining, and confocal imaging. To reduce the cost associated with using the
U-well plates, flat bottom U-wells were coated with agarose prior to cell seeding and culture. A
co-culture of 3T3 and KRTs (stained with CellTracker Red) were also cultured in U-wells as a
first step towards promoting KRT stratification into spheroids.
3.5.1 3T3 Cell Culture
NIH 3T3 Fibroblasts were cultured using aseptic technique in a 370C, 5% CO2 incubator
prior to experiments. 3T3 media was made by adding Fetal Bovine Serum (F8317, Millipore
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Sigma, St. Louis, MO) to DMEM media (12001-000, VWR, Visalia, CA), and PenicillinStreptomycin-Amphotericin (PCS-999-002, ATCC, Manassas, VA). The media was sterile
filtered and stored at 40C for up to one month.
3.5.2 Methylcellulose
A 2% weight/volume solution was chosen for the concentration of methylcellulose based
on previous literature [72], [73]. 5 grams of methylcellulose powder (M7140-100G, Millipore
Sigma, St. Louis, MO) was weighed and added to 250 mL of Distilled H2O and slowly brought to
a boil for 5-10 minutes. A stir bar was added to enhance mixing. The solution was agitated and
heated until all methylcellulose particles were wet and evenly dispersed. The solution was
immediately sterilized for 16 minutes at 1210C and 15 Pounds per Square Inch (PSI) steam
pressure. The sterile methylcellulose was stored at room temperature to facilitate complete
dispersion.
3.5.3 Cell Seeding
Cells were mixed with 20% methylcellulose solution diluted in cell media. The seeding
density was varied per experiment. 200µL of cell-20% methylcellulose was pipetted into each
well of 96-well Corning® spheroid microplates with ultra-low attachment surface (CORN4520,
VWR, Visalia, CA) and incubated for 3-5 days. Spheroids were visually assessed for growth and
health every two days.
For co-culture dual experiments with 3T3 fibroblasts and KRTs, the seeding density ratio
was matched by the media concentration. In some concentrations, the amount of methylcellulose
was increased to 40%.
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3.5.4 Agarose
Agarose (V0710-25G, VWR, Visalia, CA) was used to coat the bottom of 96-well flat
bottom plates to make the surface non-adherent and promote cell aggregation into spheroids.
Agarose plates are a potentially less expensive alternative to the Corning® ultra-low attachment
spheroid microplates.
Each well was coated with 100µL of 1% sterile agarose. 0.1 gram of agarose powder was
added to 10mL of distilled H2O and microwaved for about 1 minute until the agarose powder was
dissolved. The heated solution was immediately sterilized with a 0.22µm filter then dispensed
quickly into each well. Efficiency and rapid pipetting was required before the agarose solution
cooled and solidified in the pipet tip. The agarose in each well was allowed to gel for at least 1
hour at room temperature before seeding the cell-20% methylcellulose solution.
3.5.5 Manipulation, Staining, Plating
After 3-5 days of culture, each individual spheroid was removed from the well with a
1000µL pipet tip and placed into a 1mL conical tube. Generally, 3-5 spheroids were pipetted into
each tube. Given the density of the spheroids, they naturally accumulated at the bottom of the
tube, and the residual media and/or stains were carefully removed/added without disturbing the
spheroids at the bottom. One PBS wash was performed by slowly introducing 200µL to each
conical tube, pipetting gently to mix, then removing the liquid.
Spheroids were fixed with 3.75% PFA for 20 minutes, then rinsed three times with PBS
to remove residual fixative. Hoechst stain in PBS was introduced at various concentrations to the
spheroids by adding 200µL to each tube and gently mixing. After the staining treatment, Hoechst
was gently removed and washed three times with PBS. 200µL of PBS was left in each conical
between staining and imaging.
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Immediately prior to imaging, the stained and washed spheroids were plated in glassbottom 8-well plates by aspirating the 200µL PBS with a 1000µL pipet tip. The tip was pushed
towards the bottom to ensure all the spheroids were aspirated into the tip. The entire 200µL liquid
in the pipet was quickly ejected into one well of the 8-well plate. This process was performed
rapidly to prevent spheroids from sticking to the plastic pipet tip. The spheroids sink to the
bottom of the plate and are easily visualized under the confocal microscope.
3.6 Confocal Imaging
Images were obtained with an Olympus FluoView FV1000 confocal microscope
(Olympus America, Centerville, PA) with FluoView program. The software applied DAPI for
Hoechst, 488 laser (for Alexa Fluor 488), 559 laser (for Alexa Fluor 594), and 635 laser (for
Alexa Fluor 647). The 60X and 100X oil objectives were used to yield sufficient resolution for
fluorescence distribution analysis. The laser scanning speed was set to 4.0 µs/pixel and image
size was 512x512. Sequential was checked for multiple laser images.
Images were deliberately taken in the center of the well to ensure equal distribution of UV
radiation exposure. Z-stacks with a 1µm step size were taken to provide a more realistic 3D
image. The following settings were maintained between experiments used for quantification
purposes (Table IV and V).
Table IV: Fixed Trafficking with FSM and Post-UV
Laser and Power
488 (10%)

Stain
FSM

PMT Sensitivity
540 HV

Table V: Dual Staining with FSM, Lysenin, Ceramide
Laser and Power
488 (30%)
559 (30%)
635 (30%)

Stain
FSM
AF 594 (Lysenin)
AF 647 (Ceramide)
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PMT Sensitivity
645 HV
830 HV
715 HV

3.7 Image Analysis
The software used for image analysis was ImageJ/Fiji, a public software based on the Java
programming language and developed by the National Institutes of Health. MATLAB was also
used as a component of the 2D Fluorescence Distribution analysis, and for quantifying areas
under the resulting curves.
3.7.1 P21 Ratios
To demonstrate a reduction in p21 DNA damage marker expression in SM-treated cells,
the ratio of p21 positive to total cells was calculated. P21 positive cells exhibited bright nuclear
fluorescence compared to cytoplasm expression. For each well, the number of positive p21 cells
was manually counted with an ImageJ cell counter, then compared to the overall number of cells.
3.7.2 2D Fluorescence Distribution
A fluorescence distribution macro, developed previously by another student in the lab,
was used to analyze all fluorescence distributions. Appendix A includes the code. Raw confocal
images in .oib format were collected from the Fluoview imaging system and opened into
ImageJ/Fiji. Color channels were separated. When analyzing z-stacks, an image representative of
the middle of the cell was selected (as determined by a clear nuclear signal, and distinct absence
of FSM signal colocalization in the nucleus). Each nucleus in the image was blurred (Gaussian),
made binary, outlined, and counted. The borders of the FSM Region of Interest (ROI) were
identified in a similar manner, and the nuclei was subtracted from the FSM ROI (so that only the
cytoplasm was included). All pixels outside the cytoplasm and nuclei ROI were set to zero.
A rotation ROI was run by finding the center of the ROI, rotating a line 360 degrees
about the center, and measuring the profile plot distribution across the line for every 6 degree
angle increment. In total, 60 profile plots were generated for each cell. Because the nucleus was
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not exactly centered in all cells, the profile plots from nucleus to plasma membrane were not the
same length and number of pixels. Therefore, MATLAB was used to average all 60 profile plots
and normalize by interpolating data points (linear approximation between pixels) so that all plots
had the same number of points (“0” through “100” with “0” and “100” representing the center of
the nucleus and edge of the cytoplasmic ROI respectively). Within each image, cell profile plots
were averaged, then all images within the same well were averaged. Finally, all wells within each
treatment were averaged to yield a mean gray value fluorescence distribution versus distance
from the nucleus. Standard errors were calculated based on well to well variability within each
treatment.
Relative amount of intracellular fluorescence was calculated by finding the area under
each fluorescence distribution curve with the cumulative trapezoidal numerical integration
function (CUM TRAPZ). The area was used as a method of comparison for fluorescence
distribution curves.
3.7.3 Depth of Dye Penetration into Spheroids
The depth of Hoechst dye penetration was calculated by first subtracting all stack slices
below a consistent threshold value used for all images. Then each stack was normalized and
divided into 10 equal increments (i.e. one increment = total height/10) stepping through the entire
stack from start to finish. The entire stack was z-projected and an ROI outline of the spheroid was
generated with an ImageJ macro. For each increment slice, the fluorescence distribution codes
were used with the same ROI generated in the previous step for all increment images. Finally,
MATLAB was used to find the area under the fluorescence curves for each slice in order to
determine the dye content over the depth of the spheroid.
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4. SUMMARY OF EXPERIMENTS
All conducted experiments are listed in Table VI according to the thesis project goals.
Table VI: Thesis Goals for Characterizing FSM, Staining Protocols, and 3D Cell Spheroids

Goal

Summary of Experiments
Initial FSM Imaging
Goal: Validate protocol methods for 5µM FSM
Live FSM Intracellullar Trafficking
Goals: Visualize FSM distribution differences over various FSM
incubations; assess suitability of live imaging

1
Characterize
FSM

Develop Staining
Protocols

3

4.2
4.3

Fixed FSM Trafficking with Variable Incubation Times
Goal: Quantify FSM distribution differences over several FSM
incubation times in fixed cells

4.4
4.5

4.6
4.7

Lysenin Stain Optimization
Goal: Determine optimal staining parameters

4.8

Ceramide Stain Optimization
Goal: Determine optimal staining parameters

4.9

Dual Lysenin, Ceramide, and FSM Staining
Goal: Validate protocol methods for dual immunofluorescence

4.10

Troubleshooting FSM Degradation after Dual Treatment
Goal: Identify one reason for FSM degradation dilemma
Dual Lysenin, Ceramide, and FSM Fluorescence Trafficking
Goal: Quantify Lysenin, Ceramide, and FSM distribution
differences over several FSM incubation times in fixed cells

Cultivate 3D
Spheroids

4.1

FSM Temperature Dependence
Goal: Assess temperature-dependent FSM uptake

Fixed FSM Trafficking with UV
Goal: Detect UV perturbations in FSM distribution
P21 Ratios for BSM and FSM Comparison
Goal: Demonstrate functional equivalence of p21 photoprotection
for FSM and BSM
FSM with Nile Red
Goal: Determine suitability of Nile red stain

2

Thesis
Section

KRT and 3T3 Single Culture
Goal: Validate spheroid protocol methods
KRT and 3T3 Dual Culture
Goal: Assess KRT-3T3 dual spheroids
3T3 Culture with Agarose-coated Wells
Goal: Test agarose coating, Triton X and FSM incubations
Quantification of Spheroid Dye Penetration
Goal: Quantify dye penetration into spheroids
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4.11

4.12
4.13
4.14
4.15
4.16

4.1 Initial FSM Imaging
4.1.1 Summary and Objectives
The goal of the first FSM experiment was proof-of-concept to demonstrate that FSM at a
5µM concentration is detectable by confocal imaging and yields a bright signal with low noise.
This concentration is consistent in literature, with research groups employing either a 5µM or
4µM FSM concentration [59], [65], [82]–[84]. Furthermore, ThermoFisher’s product guidelines
for fluorescently labeled sphingolipids specified complexing 5µM FSM with 5µM BSA in PBS
[82]. Therefore, a 5µM FSM diluted in 5µM BSA (in PBS) was chosen as the starting
concentration for all experiments.
The past FSM literature imaged live cells to visualize trafficking and intracellular
localization [58], [59], [84], and fixing cells prior to imaging was not addressed. However,
research with Bovine Milk SM (BSM) at the Cal Poly Bioimaging Lab involved cell fixation
prior to imaging [13], [14]. Therefore, to bridge the gap between FSM and BSM research, a
secondary goal was to fix FSM-treated cells with 3.75% PFA to determine if the exogenous FSM
signal was conserved after fixation (i.e. FSM can survive cell fixation).
200µL of 5µM FSM diluted in 5µM of BSA (in PBS) was introduced to a monolayer of
live KRT cells cultured in glass coverslip 8-well plates and incubated at 370C for 1 hour. After
incubation, the FSM media was removed and washed gently with PBS. Samples were either
imaged live or fixed in 3.75% PFA immediately prior to imaging. Confocal images were taken on
the 40x and 100x objective.
4.1.2 Results
Figure 20 includes images of the first FSM experiment. Figure 20A depicts fixed KRT
cells with FSM, while Figures 20B-D involve live cell imaging without 3.75% PFA fixation. The
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FSM signal for both fixed and live cells appeared robust with an apparent high signal to noise
ratio. Visually, no differences in signal brightness was visualized between the fixed and live cells.

A

B

C

D

Figure 20: First FSM Study. (A) Fixed cells at 40x objective demonstrating that FSM signal
survives PFA fixation, but a higher objective is a better indicator of intracellular fluorescence
distribution. (B) Live cells at 100x objective showing blebbing (white arrow) from
endocytosis/exocytosis, a mechanism for cellular FSM entry/exit. (C) Time image of live cells at
100x objective. FSM is predominantly concentrated in the plasma membrane, with some
intracellular accumulation. (D) Time image, 100x objective, with intracellular distribution (white
arrow) of FSM into cells.

Figure 20B-D were also taken on a higher confocal microscope objective (100x oil)
compared to Figure 20A (40x oil). The higher magnification with larger numerical aperture
(N.A.) enabled better visualization of intracellular FSM distribution. As shown by the white
arrow in Figure 20D, clusters of fluorescence around the nucleus were visualized with the 100x
objective. In addition, cellular phenomena like blebbing were observed, as demonstrated in
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Figure 20B. Blebbing, plasma membrane protrusions during endocytosis and exocytosis of lipid
and cellular byproducts, is a scientifically characterized process. The blebbing observed during
imaging most likely occurred as cells endocytose, metabolize, and exocytose exogenous lipids
like FSM.
4.1.3 Discussion
The previously described experiment demonstrates that FSM incubation in KRT cell
monolayers yields a bright and easily detectable signal. Furthermore, FSM can undergo fixation
without a significant change in brightness or visual appearance. In addition, a higher objective
with larger N.A., like the 100x, yields better resolution and is the objective of choice for future
trafficking experiments involving intracellular fluorescence visualization. Lastly, two phenomena
were visualized, both supported by literature [58], [60], [63], [84]. First, blebbing - protrusions of
the plasma membrane - was observed as a potential indicator of FSM endocytosis or exocytosis.
The cell accumulated FSM from its external supply in the media, then released its contents back
into the environment. Endocytosis and exocytosis potentially mediate lipid homeostatic levels and
have been characterized in scientific literature [63]. Furthermore, FSM accumulated in the plasma
membrane of the KRT cells, then moved intracellular as clusters of fluorescence around the
nucleus. The intracellular migration of FSM to regions close to the nucleus is also documented in
literature [58], [60], [84]. Both phenomena observed in this first FSM study – blebbing and
intracellular fluorescence migration – are important because they mirror published results and
demonstrate that the current protocols (i.e. 5µM concentration, solution preparation, incubation
with cells, and imaging) are sufficient to obtain scientifically relevant results.
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4.2 Live FSM Intracellular Trafficking
4.2.1 Summary and Objectives
In the context of this thesis, trafficking is defined as the fluorescence distribution of FSM
both inside and along the plasma membrane of a cell. Differences in FSM trafficking were
compared and qualitatively assessed among image treatments by location (i.e. near the nucleus
versus concentrated in the plasma membrane) and/or in brightness of signal (correlated with the
amount of FSM present in a specific location). Location could then be correlated with metabolic
activity [27]. The main goal of the following experiment was to determine qualitatively if FSM
trafficking in live KRT cell cultures changed as a result of the 370C incubation time. It is
important to note that cultures were not washed with PBS prior to imaging because the goal of
this study was to assess the native in vitro FSM trafficking dynamics during continuous FSM
incubations.
A secondary goal was to assess the suitability of live cell confocal imaging for FSM
trafficking experiments. Live imaging presents a method to visualize live FSM trafficking within
the same cell culture system. However, live microscopy can yield challenges which can affect
image quality and cell phenotype. For example, continuous laser exposure during time scans of
the same cell can photobleach the signal and yield a decrease in fluorescence brightness.
For the experimental procedure, a 370C FSM incubation was used because previous
experiments demonstrated FSM entry was temperature-dependent and a 370C incubation was
chosen for consistency [58], [59]. KRTs were cultured in 8-well plates and incubated with 200µL
of 5uM of FSM for 10 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 12 hours, and 24
hours. FSM media was not removed prior to imaging in order to probe the cell conditions during
a continuous FSM incubation. Cells were then imaged on the confocal at 100x objective, and both
static and time-lapse images were acquired.
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4.2.2 Results
For this experiment, FSM was continuously incubated for 10 minutes, 30 minutes, 1
hour, 2 hours, 3 hours, 4 hours, 12 hours, and 24 hours. The 488 laser was used at 15% power and
611 PMT sensitivity. Timescan images (sequential 2D images over a specified time range and
laser pulse) were obtained for each timepoint. Specifically, each treatment Region of Interest
(ROI) was imaged for 5 minutes, with 5 seconds between each laser pulse for a total of 60
images). Even after only 10 minutes of incubation, FSM was observed both at the plasma
membrane and in the cytoplasm (Figure 21).
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Figure 21: Representative Images for Live FSM Trafficking with Variable Incubation
Times. (A) 10 Minutes (100x), (B) 1 Hour (100x), (C) 12 Hours (100x). No difference in
trafficking was observed between all timepoints, suggesting endocytosis and exocytosis
homeostasis is reached early in the cell. The plasma membranes had a “shaggy” or coarse FSM
staining because cells were directly probed during FSM media incubation and a wash step with
PBS was not performed prior to imaging.
More specifically, a bright plasma membrane staining was observed, and the staining was
more intense compared to the first experiment. The reason for this could be due to the lack of
FSM media washing prior to imaging. In the previous experiment, one gentle PBS wash was
performed to remove residual extracellular FSM staining. The increase in plasma membrane
fluorescence and coarse “shaggy” FSM appearance could be due to residual FSM weakly
adherent to the plasma membrane that is usually washed off with PBS rinses.
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No qualitative change in fluorescence distribution or intensity was observed for all the
timepoints. Whitelight overlaid with AF 488 images indicated that fluorescence distribution
seemed to locate around the nucleus in the Golgi bodies, an observation which is supported by
literature [58], [60], [84]. Figure 22 includes one static image of a 3 hour incubation, which
serves as a representative image for all timepoints.
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B

Figure 22: Three Hour Incubation Live Cells with FSM and DIC. Representative image of all
timepoints (10 minutes – 24 hour incubation) at 100x objective. Relatively consistent staining
was observed among all timepoints. Intracellular fluorescence was concentrated around the
nucleus in what appeared to be Golgi bodies (black arrow). Inset is an overlay of AF 488 (A) and
DIC (B - whitelight).
While taking timescans, significant photobleaching was observed. In addition, the cells
appeared to move during the scan. In some cases, the cells shifted upwards and away off the
coverglass. To demonstrate observed cell movement and photobleaching during imaging, Figure
23 shows an image at the beginning of the scan (Figure 23A), and after 5 minutes of imaging with
5 second pauses between laser scans (Figure 23B). Figure 23C shows an overlay of the first and
last image of the timescan with Figure 23B pseudocolored blue.
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Figure 23: Severe Photobleach of Live FSM Timescans. (A) First image of live timescan. (B)
Last image of live timescan (after 5 minutes with 5 seconds between laser pulses) showing
photobleaching, especially evident in the intracellular space. (C) Overlay of first image with
pseudo-colored blue last image. The blue signal plasma membrane forms a halo around the green
plasma membrane, suggesting the cell is pulling away from the plate and shifting upward in the zaxis.
A profile plot for the purple line in Figure 23 was generated through ImageJ and
reproduced in Figure 24. The green and blue curves represent the first and last image in the time
series respectively.
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Figure 24: Profile Plot of Signal Degradation and Cell Movement Over Time. The profile
plot was constructed from the line drawn across the image in Figure 22. Green represents the first
image and blue the last image in the scan. (A) intense plasma membrane localization, (B)
intracellular fluorescence clusters near the Golgi elicit small spikes in fluorescence, (C) lack of
signal in the nucleus. The blue plot has a significantly lower mean gray value and is shifted
outward compared to the green line.
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The intense peaks labeled with “A” in Figure 24 represent the plasma membrane, where
two spikes in fluorescence are observed. In between the plasma membrane peaks are smaller
peaks as indicated by “B”. These correspond to intracellular fluorescence outside the nucleus,
possibly in the Golgi. Finally, the drop in fluorescence at “C” indicates the nucleus, where a lack
of fluorescence signal is observed.
Comparing the two curves, the blue exhibited a noticeably lower mean gray value than
the green curve, demonstrating the observed photobleaching or fluorescence decrease in signal
intensity due to prolonged laser exposure. The two peaks representing the plasma membrane also
appeared to shift slightly outward, suggesting movement of the cell during imaging.
4.2.3 Discussion
The live trafficking with different continuous 370C incubation times suggested no
difference in FSM intensity or localization over time. Both intracellular and plasma membrane
staining was apparent even after just 10 minutes of incubation, and the location and relative
intensities of the FSM signal during the start of each timescan were comparable. However, after
the duration of the imaging, severe photobleaching and slight cell movements were observed. In
addition, the plasma membrane fluorescence was brighter with an uneven, coarse FSM staining
appearance compared to the previous live imaging experiment, potentially because the FSM
solution was not washed off prior to imaging and residual FSM weakly adherent to cells was not
removed with washing.
Moving forward, treating the cells with FSM, washing off residual weakly adherent FSM,
then fixing the cells with 3.75% PFA prior to imaging is preferable to live imaging because of the
extra variability live imaging exhibits. Although live imaging warrants a more physiologically
relevant real-time view of the cell, photobleaching and cell movement can skew data and make
image analysis difficult. In addition, the lab was not equipped with a stage heat plate to keep the
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cells at 370C so extended imaging durations could negatively affect cell phenotype. Extended
imaging of the same cell culture past 1 hour is not possible with the equipment available in lab.
Given the difficulty accounting for photobleaching and cell movement, future work proceeded
with a more consistent fixed cell approach.
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4.3 FSM Temperature Dependence
4.3.1 Summary and Objectives
The goal of the subsequent experiment was to determine if the uptake of FSM is
dependent on whether FSM is incubated at 370C prior to imaging. In other words, the goal was to
assess if FSM entry into cells is temperature-dependent. It is hypothesized that a 370C incubation
with the FSM media facilitates faster FSM incorporation into the cell [59]. In previous
experiments with BSM, the lipid was also introduced to cells and incubated at 370C prior to UV
radiation and imaging [13], [14]. If FSM uptake is indeed temperature-dependent for KRT
monolayers, ensuring that cells are consistently incubated with FSM at 370C prior to
experimentation is necessary in order to reduce extraneous variability. For this experimental
protocol, freshly-made FSM was introduced to cells at room temperature and then immediately
imaged by taking consecutive time series images. Images were compared to results obtained in
previous experiments.
4.3.2 Results
Figures 25A-D represent various timepoints within an almost 2-hour imaging session. In
the beginning, FSM accumulated in the plasma membrane (Figure 25A-B). Only after about 6090 minutes of live imaging at room temperature did FSM move intracellularly (Figure 25C-D).
Furthermore, the intracellular movement was found to be highly heterogeneous and inconsistent,
with some cells displaying bright cytoplasmic expression (Figure 25B white arrow).
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E t ~ 75 min

A t ~ 30 min

B t ~ 60 min

C t ~ 75 min

D t ~ 90 min

F

G

H t ~ 90 min

Figure 25: Rapid FSM Entry and Temperature Dependence. (A-D) FSM after approximately
90 minutes (100x objective). Heterogeneous staining is apparent. Some cells start rapidly
accumulating FSM, but uptake is highly variable among cells. (E-H) Representative time images
between C and D panel of plasma membrane blebbing and release of FSM into extracellular
space after 90 minutes. 100x objective.
Blebbing was again observed, as a cell released FSM to the extracellular space. Figure
25E-H are zoom-in time-lapse images of cells contained within the white box in Figure 25C. As
indicated by the white arrows in Figures 25E-H, the cell bleb diminishes in diameter, then
eventually releases its fluorescent contents into the extracellular space, most apparent in Figures
25G-H.
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4.3.3 Discussion
The previously described experiment suggests that FSM entry and intracellular staining
does indeed depend on the temperature. Even after 60-90 minutes of imaging, cytoplasmic
staining was inconsistent and heterogenous within the Figure 25 ROI. Some cells displayed bright
intracellular fluorescence while others did not. The images suggest endocytic and exocytic
blebbing processes are conserved, but perhaps occur at a slower rate because the cells were not
cultured at physiologically relevant temperatures (370C). Incubation with FSM prior to imaging
seems to ensure consistent, homogenous fluorescent labeling of the cells. This experiment
suggests that the temperature of FSM incubation is one, of potentially many variables, that need
to be conserved in subsequent experiments to reduce variability. It also serves to explain the
behavior of BSM which could not be assessed in past research. In the future, all experiments will
involve FSM incubation at 370C.
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4.4 Fixed FSM Trafficking with Variable Incubation Times
4.4.1 Summary and Objectives
The goal of this experiment was to quantitively determine if FSM localization in a cell
varied over a spectrum of continuous incubation times (10 minutes, 30 minutes, 1 hour, 2 hour, 3
hour, 4 hour, 12 hour, 24 hour). Previous live images suggested that the distribution did not
fluctuate significantly, but more consistent methods need to be utilized to yield data worthy of
analysis (i.e. PBS wash to remove residual FSM, image a fixed cell culture). In addition, a larger
sample size and image analysis program to quantify fluorescence are both necessary to make a
conclusion. The results of this experiment are important because fluorescence distribution
analysis could point towards an optimal incubation time for the SM treatments.
Eight 8-well plates with monolayers of KRTs were independently incubated with FSM at
370C for varying timepoints. Immediately after treatment, cells were gently washed once with
PBS then fixed with 3.75% PFA. Six wells (n=6) per treatment (3 images/well) were imaged on
the confocal using identical laser settings. 2D images were post-processed in ImageJ using the
trafficking and rotation ImageJ and MATLAB programs to obtain the mean gray values over
normalized distances from the nucleus. Finally, the area under each curve was calculated using
MATLAB and plotted. ANOVA and Tukey HSD post-hoc tests were performed on the area data.
4.4.2 Results
Figure 26 includes representative images of fixed images during variable FSM
incubations. Figure 26A-D show representative images for 10 minutes, 1 hour, 12 hour, and 24
hour, respectively. Throughout all incubation times, the signal intensity and localization appeared
to be conserved. Figure 26E and F includes a profile plot of a line drawn across the boxed cell in
Figure 26A. The plot demonstrates that a brighter intracellular signal (red arrow) and dimmer
plasma membrane signal (black arrow) are present in most cell images.
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A t ~ 10 min

B t ~ 1 hr

C t ~ 12 hr

D t ~ 24 hr

E

Figure 26: Fixed FSM Trafficking with Variable Incubation Times. (A) 10 min, (B) 1 hour,
(C) 12 hour, (D) 24 hour, (E) Profile plot line draw across the boxed cell for the 10 minute
treatment. (F) Corresponding profile plot. Red and black arrows denote intracellular and plasma
membrane fluorescence respectively. Fluorescence localization and brightness appears to remain
consistent regardless of incubation time. 100x objective.

To quantify intracellular fluorescence distribution, the 2D Fluorescence Distribution
macros were utilized. Briefly, Region of Interests (ROIs) were drawn around each cell to outline
the cytoplasm and nucleus. Lines were extended from the center of each cell nucleus and rotated
3600 at 60 increments. The profile plots along each line were averaged. Finally, a MATLAB code
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was used to normalize the average profile plot. Figure 27 includes three representative profile
plots (Figure 27A-C) and an outlined cell ROI with corresponding profile plot lines extending
radially from the nucleus center (Figure 27D).
A

B

C

D

(B)

(C)
(A)

Figure 27: Example Workflow of 2D Fluorescence Distribution. (A-C) Profile Plots
corresponding to the lines in (D). For each cell within the image, an ROI was drawn to
encompass the cytoplasm and exclude the nucleus (purple outline). Lines extending radially from
the centroid were formed and rotated 3600 at 60 increments. In total, 60 profile plots per cell were
generated. The profile plots along each line were averaged, then the distance was normalized in
MATLAB by linear interpolation between points.
The final result of the fluorescence distribution macros was one curve of mean gray value
on the y-axis and normalized distance from the nucleus on the x-axis. Data from each cell within
the image was averaged. Then all three images/well were averaged to obtain one mean gray value
vs. normalized distance for each well. Finally, each of the six wells were averaged to yield an
average fluorescence intensity curve. Figure 28 includes results of the trafficking data analysis
for all eight continuous incubation times (10 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour,
12 hour, 24 hour).
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Figure 28: FSM Trafficking with Different Continuous Incubation Times (n=6). Standard
error bars are represented.

Over time, the mean gray values slightly fluctuated close to the nucleus, but the variation
and intensity considerably diminished farther from the nucleus. The results were supported by
previous visual assessment (Figure 26). Independent of the incubation time, the signal was bright
around the nucleus, and decreased in intensity farther from the nucleus.
The amount of intracellular FSM corresponding to each treatment was also quantified by
calculating the area under each curve with the CUM TRAPZ function in MATLAB. This was
done to verify that FSM did not fluctuate significantly over various incubation times. It was
expected that curves with a similar shape would yield similar area-under-the-curve
measurements. Figure 29 includes a graphical representation of the area calculations. The relative
amount of cytoplasmic fluorescence is plotted over 1 hour, 2 hour, 3 hour, 4 hour, 12 hour, and
24 hour FSM continuous incubations.
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Figure 29: Relative Amount of FSM in a Cell over Various Timepoints (n=6). # is p<0.05 for
pairwise comparisons. $ is p<0.05 compared to global mean. No other significant pairwise
differences between the groups according to Tukey HSD. Standard error bars are represented.
The statistical assumptions were met. Data was normally distributed with equal variances
(Appendix B). Furthermore, since each datapoint represented an average of all images within six
different wells on a plate, independence was assumed. The 3 hour treatment (M 100.8k, SE 9.2k
summative mean gray value) was statistically greater (16.6%) than the global mean (M 96.7k, SE
5.28k summative mean gray value) with p-value of 0.0050. The 12 hour average (M 82.93k, SE
6.09k summative mean gray value) was statistically lower (11.3%) than the global mean with pvalue of 0.0413. Tukey HSD p-value correction was performed on the data and an ordered
differences report was generated to perform pairwise comparisons among the timepoints. The
data demonstrated that no significant pairwise differences existed when comparing each
timepoint to the other except for 3 hour versus 12 hour. Specifically, the average relative amount
of fluorescence for 12 hours was 23.9% lower than the average relative amount for 3 hours (p
0.0279).
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4.4.3 Discussion
Since data matched observed images, the trafficking and rotation program proved to be a
useful analysis technique for the experimental data. The fluorescence distribution in a cell did not
change significantly among the timepoints. Although the relative amount of FSM differed
between 3 hours and 12 hours, the biological mechanism or significance is unknown. Since this
was the only pairwise difference observed in the entire dataset, the difference was deemed to be
an artifact of imaging error rather than biological significance. The amount of FSM added is finite
and a cell cannot spontaneously generate more intracellular FSM at 3 hours, as the data possibly
indicates. For example, fluctuations in laser performance between imaging sessions or small
differences in FSM media volume introduced to the cells could induce slight deviations in FSM
cytoplasmic fluorescence brightness.
The data suggests that with a continuous supply of FSM in the media, an equilibrium is
reached and the cell endocytoses and recycles FSM back to the plasma membrane for exocytosis
at an equal rate. Intracellular fluorescence occurs even after just 10 minutes of 370 C incubation.
The distribution, brightness, and amount of intracellular FSM is also independent of continuous
incubation duration. Although contrary to the preliminary hypothesis (Section 2.15), these
experimental results suggest that a shorter timepoint for SM incubation prior to UV could be
sufficient (i.e. possibly a 1 hour incubation instead of 24 hours). The previous 24 hour incubation
was chosen based on literature and prior to FSM adoption [13], [14]. Incubating for one hour can
decrease experiment time enabling more convenient and efficient experiments.
Limitations of this experiment include potential error and bias introduced by the analysis
program (Figure 30). For example, it was difficult for the program to distinguish surrounding
bubbles or blebs from the cytoplasmic outline.
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Figure 30: Troubling ROIs. (A) Inaccurate cellular outlines encompassing localized bubbles
and blebs (white arrow). (B) Potential cell area data bias. 100x objective.

Resulting protrusions in the outline (Figure 30A white arrow) can potentially skew data
since all fluorescence within the ROI is quantified. Furthermore, a large cell versus small cell
area potentially introduces data bias that could affect data. Cells with a larger area (Figure 30B)
have more cytoplasm and more space between the concentrated Golgi fluorescence and plasma
membrane, thus changing the fluorescence gradient and line profile plots. Although data
normalization attempts to account for differences in cell size, the full extent of the cell area
contribution to the data is unknown. In the future, accounting for cell size would be desirable to
determine if a significant interaction exists between fluorescence distribution and cell area.
Finally, the analysis program excludes multi-nucleated cells, and cells along the edge of
the image field of view. Furthermore, the program has difficulty outlining out-of-focus images.
Improvements to the actual program and implementation for 3D image sets would prove
advantageous for the future.
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4.5 FSM Trafficking with UV
4.5.1 Summary and Objectives
The next step in the progression of goal 1 was to introduce UV to the system. The main
goals of the following experiments were to determine if a 40 mJ/cm2 UV radiation to a monolayer
perturbs intracellular FSM fluorescence distribution and relative amount. Based on a search of
recent literature, ceramide levels have been shown to increase after UVB radiation in KRT skin
cells which offers photoprotection by increasing the apoptosis rates of potentially damaged cells
[24]–[26]. However, the intracellular levels of SM in an irradiated cell are less characterized.
Currently, no research groups combine exogenous SM treatment with UVB radiation in KRTs to
quantify intracellular SM levels. Wanner et al. added a bolus of 5µM exogenous FSM to KRT
cells and used High Performance Thin Layer Chromatography (HPTLC) to demonstrate a 25%
decrease in SM levels to ceramide after 3 hours because of increased hydrolysis by SMase as the
cell reaches homeostasis [85]. No UV was introduced to the system. Furthermore, Charruyer et al.
and Uchida et al. claimed that ceramide levels increased, but SM levels surprising remained
unchanged and did not fluctuate after UV [24], [25]. The ceramide increase was more likely due
to CERT dysfunction after UV and was independent of SM levels [24]. However, exogenous SM
was not administered, and endogenous levels were only quantified with HPTLC. Additionally, a
fluorescence imaging methodology to visualize cellular fluorescence was not employed.
Despite the recent studies, it is unknown whether the addition of both exogenous FSM
and UV perturb lipid levels in a significant manner in KRT cells based on fluorescence
intracellular distribution analysis. Based on previous research, it was hypothesized that FSM
levels would either clearly decrease compared to the no UV control (as FSM is metabolized to
ceramide) or remain relatively stable compared to the no UV control (because other mechanisms
account for the increase in ceramide). However, the fate of the fluorescent probe is unknown. In
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this current experiment, cells were introduced to FSM for 1 hour or 24 hour continuous
incubations, FSM was removed, media was exchanged, and cells were immediately subjected to
40 mJ/cm2 of UVB radiation. Cells were fixed 1 hour, 2 hour, 12 hour, and 24 hour post-UV.
Three confocal images were taken of each well for a total of 6 wells (n=6) in the 1 hour
incubation case and 4 wells (n=4) in the 24 hour incubation case. For the control, exact conditions
were replicated for the 24 hour plate, except no UV was administered. The role of the control was
to delineate metabolism from UV effects when explaining sources of observed FSM fluctuations
in cells.
4.5.2 Results
Figures 31 and 32 include results of the post-UV fluorescence distributions for a 1 hour
and 24 hour continuous incubation. Within each FSM incubation treatment, cells were fixed 1
hour, 2 hours, 12 hours, and 24 hours post-UV and imaged on the confocal. 2D fluorescence
distribution analysis was conducted on 3 images per well for a total of 6 wells and 4 wells in the 1
hour and 24 hour incubation treatments respectively. Within each incubation time, the shape of
the distribution curve remained consistent, with a spike around the nucleus and decreasing signal
approaching the plasma membrane.

76

Figure 31: Fluorescence Distribution for 1 Hour Incubation (n=6 wells). Control (no UV) for
the 24 hour timepoint is denoted in black. All post-UV timepoints exhibit similar mean gray
values and are grouped close together, with the exception of the no UV control with demonstrates
a visible reduction in average mean gray value around the nucleus and throughout the cell.
Standard error bars are represented.

Figure 32: Fluorescence Distribution for 24 Hour Incubation (n=4 wells). Control (no UV)
for the 24 hour timepoint is denoted in black. All post-UV timepoints have similar mean gray
values throughout the cell and are grouped close together including the no UV control. Standard
error bars are represented.
For the 1 hour FSM incubation, the 12 hour curve exhibited a more gradual decline in
FSM with higher mean gray values. Additionally, the no UV control (Figure 31 black curve) had
a lower mean gray value throughout the cell. All post-UV timepoints within the 24 hour FSM
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incubation including the no UV control (Figure 32 black curve) demonstrated similar mean gray
values and curves were grouped close together.
When comparing 1 hour and 24 hour incubation after various post-UV fixation times, one
trend was apparent (Figure 33). In the 1 hour, 2 hour, 12 hour, and 24 hour post-UV conditions,
the 1 hour FSM incubation time (indicated by the black curve) consistently exhibited a larger
mean gray value compared to the 24 hour FSM incubation (gray curve).

Figure 33: Comparison of Post-UV Fluorescence Distributions for 1 Hour and 24 Hour
FSM Incubation. The 1 hour FSM incubation (black curve) had a consistently larger mean gray
value compared to 24 hour FSM incubation (gray curve) along the entire cell distance from the
nucleus. Standard error bars are represented.
Finally, to confirm the trends demonstrated by the fluorescence distribution graphs, and
to provide numbers for statistical data analysis comparisons, the area under each curve was
quantified and plotted in Figure 34. Data was normally distributed with equal variances
(Appendix B).
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Figure 34: Relative Amount of Cytoplasmic Fluorescence for Various Times after UV. #, $,
%, ε, *, & denote statistically different comparisons between the two with the same symbol
(p<0.05). Standard error bars are represented.

Tukey HSD pairwise comparisons were conducted in two ways: 1) within the same FSM
incubation time (either 1 hour or 24 hour) to compare among post-UV timepoints, 2) within each
post-UV timepoint (either 1 hour, 2 hours, 12 hours, or 24 hours) to compare between FSM
incubation times. Within the 24 hour FSM incubation treatment, no significant pairwise
differences in average cytoplasmic FSM fluorescence were observed among all post-UV
timepoints and the no UV control. However, within the 1 hour FSM incubation treatment, some
differences in FSM cytoplasmic fluorescence was observed. In particular, the 12 hour post-UV
area under the curve (M 137.95k, SE 15k summative mean gray value) was significantly greater
than 1 hour (M 92.1k, SE 6.55k summative mean gray values) (p 0.009) and 2 hour (M 97.85k,
SE 5.92k summative mean gray values) (p 0.0331) by approximately 50% and 41% respectively.
Furthermore, the no UV control (M 69.96k, SE 9.22k summative mean gray values) was
significantly lower compared to the 24 hour post-UV timepoint (M 92.14k, SE 6.55k summative
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mean gray value) (p-value 0.0065, 24% decrease) and 12 hour post-UV timepoint (p-value
0.0002, 49.29% decrease).
Within the same post-UV timepoint, comparisons between the 1 hour and 24 hour FSM
incubations were conducted. The 1 hour incubation had a significantly higher average
cytoplasmic mean gray value compared to the 24 hour incubation for both the 12 hour (1hour
incubation: M 137.95k, SE 15k; 24 hour incubation: M 73.24k, SE 40.3k) (p-value 0.0004, 88%
increase), 2 hour (1 hour incubation: M 97.84k, SE 5.92k, 24 hour incubation: 75.54k, SE 6.86k)
(p-value 0.0418, 29.53% decrease), and 24 hour (1hour incubation: M 92.14k, SE 6.55k; 24hour
incubation M 66.5k, SE 69.7k) (p-value 0.005, 38.5% increase) post-UV timepoints.
4.5.3 Discussion
Based on trafficking curves and area under the curves, there appears to be an increase in
intracellular cytoplasmic cell expression for all post-UV timepoints after just 1 hour of FSM
incubation compared to 24 hours FSM incubation. Additionally, FSM levels spiked at 12 hours
post-UV for the 1 hour incubation while remaining fairly consistent throughout the 24 hour
incubation. Within the 1 hour timepoint, 24 hour post-UV had more fluorescence expression than
the control, 1 hour, and 2 hour post-UV timepoints. Lastly, no difference between the no UV
controls were observed.
It is unknown at this time why the intracellular fluorescence significantly increased at 12
hours, especially since no new FSM is introduced to the system after UV exposure. Perhaps the
increase is artificial and a result of variability or error in the measurement system or experimental
parameters. More replicates are needed to further investigate this observation. Also, given the
variability in the post-UV timepoints within the 1 hour incubation, more experiments are
warranted to further understand the effects of a 1 hour incubation. A 1 hour FSM incubation
shows promise because more variability among timepoints was observed, suggesting a 1 hour
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incubation could elicit more biologically relevant changes post-UV. For example, the significant
difference between 24 hour post-UV and control for 1 hour FSM incubation might suggest that
UV alters cells to stop metabolizing FSM. No significant difference was exhibited between 24
hour post-UV and 1 hour post-UV for the 1 hour FSM incubation. Furthermore, it is unknown
why all 1 hour incubation FSM amounts were greater than 24 hour, especially since the previous
FSM trafficking experiment demonstrated no significant difference among continuous incubation
timepoints. Perhaps a combination of variable FSM metabolism rates and UV perturbation cause
a significantly greater signal after 1 hour incubation.
According to the preliminary mechanism hypothesis (Section 2.15), intracellular levels of
post-UV FSM were expected to be lower than the no-UV control because FSM is hydrolyzed to
ceramide and the fluorescent probe is cleaved and exocytosed from the cell. The exocytosed
probe after FSM hydrolysis would result in a diminished total intracellular fluorescence.
However, the data demonstrated contrary results (post-UV timepoints had greater intracellular
FSM compared to control), highlighting the need to identify exactly where the downstream
fluorescent probe localizes in a cell after FSM hydrolysis. Future colocalization experiments with
FSM, lysenin (endogeneous SM), and ceramide could help elucidate the identity of the
fluorescent signal – whether the fluorescence is an SM (colocalized with lysenin) or a fluorescent
ceramide (colocalized with ceramide).
This experiment demonstrated the value of controls. Comparisons cannot be made
between UV and no UV for each timepoint because of the experimental conditions. The
trafficking experiments involved continuous incubations with FSM. Experimental plates for the
UV experiments, on the other hand, were incubated continuously with FSM for 1 hour or 24
hours then the media was removed and non-FSM media was replaced immediately prior to UV.
Post-UV, the cells were incubated in the regular KRT media for 1 hour, 2 hours, 12 hours, and 24
hours. Thus, a direct comparison between each trafficking timepoint and the UV timepoint cannot
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be made because two variables – the UV exposure and latent post-UV incubation in clean media
prior to fixing – confound the results. The latent incubation without a constant supply of FSM
would most likely decrease FSM intensity due to metabolism and decrease the fluorescence
intensity. If a change was observed, it is unknown whether the difference would be from UV
perturbation or FSM metabolism. The only control performed in this experiment was for the 24
hour timepoints. In the future, controls for each timepoint are necessary to draw more relevant
conclusions.
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4.6 p21 Ratios for BSM and FSM Comparison
4.6.1 Summary and Objectives
The UV photoprotection benefit of BSM was compared to FSM, a fluorescent analogue
of BSM, by quantifying the p21 positive to total cells within each well. P21 is an indicator of
DNA damaged cells. Past studies have suggested BSM photoprotection for KRTs by
demonstrating decreased p21 levels in UV exposed cells after BSM treatment compared to
control [13], [14]. However, the functional equivalence of FSM as a suitable analogue for BSM
has not been demonstrated. The goal of this experiment was to determine if FSM treatment
reduces p21 levels in KRT cells after UV radiation in a similar manner to BSM.
4.6.2 Results
Cells were incubated with either BSM or FSM for 24 hours, washed, and exposed to 40
mJ/cm2 of UV radiation. 24 hours post-UV, cells were fixed and stained for p21. The ratios of
positive p21 to total cells were quantified for each treatment. Figures 35 and 36 include
representative images of the SM treatment and control cases for both no UV and UV respectively.
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Figure 35: No UV with BSM and FSM Treatment. (Top Row) BSM (-), UV (-). (2nd Row)
BSM (+), UV (-). (3rd Row) FSM (-), UV (-). (Bottom Row) FSM (+), UV (-). Images
demonstrate relatively low p21 nuclear expression (white arrow) suggesting that SM incubations
are not cytotoxic. 40x objective.
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Merge

DAPI

AF 488 (FSM)

AF 647 (p21)

BSM (-)
UV (+)

BSM (+)
UV (+)

FSM (-)
UV (+)

FSM (+)
UV (+)

Figure 36: UV with BSM and FSM Treatment. (Top Row) BSM (-), UV (+). (2nd Row) BSM
(+), UV (+). (3rd Row) FSM (-), UV (+). (Bottom Row) FSM (+), UV (+). Reduced amount of
nuclear p21 levels (white arrow) are apparent in the SM treatment cases compared to control no
SM treatments. 40x objective.
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The above figures are separated by treatment and channel (either merge, DAPI, AF 488,
or AF 647). DAPI shows nuclei, AF 488 shows the presence (or absence) of green FSM signal,
and AF 647 indicates p21 fluorescence. The white arrow in Figure 35 demonstrates a clear lack of
p21 nuclear signal (although faint baseline cytoplasmic expression is observed). Furthermore, the
white arrow in Figure 36 denotes clear nuclear p21 expression which is easily distinguished and
brighter than the baseline cytoplasmic expression.
Visual comparison of nuclear p21 expression among the images demonstrates that the no
UV case has lower p21 expression regardless of SM treatment. The lower p21 levels suggest
introducing BSM or FSM does not elicit cytotoxicity or increased cell cycle arrest levels
compared to control. When 40 mJ/cm2 of UVB is introduced to the cells, nuclear p21 expression
increases but the number of nuclei stained in the BSM and FSM treatments are lower. This
observation supports photoprotective hypotheses for SM. Lower nuclear p21 levels correspond
with decreased cell cycle arrest and photoprotection after UV. The observations were confirmed
by calculating p21 ratios (p21 positive nuclei divided by total nuclei) for each image (Figure 37).
Three confocal images were obtained per well, and four wells were analyzed per treatment (n=4).
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Figure 37: p21 Ratio Results (n=4 wells). (A) BSM p21 Ratios. (B) FSM p21 Ratios. (C)
Comparison Between Bovine Milk SM and C6-NBD SM p21 Ratios for UV Cases. Standard
error bars are represented.

P21 ratio results displayed photoprotective trends. Appendix B includes normality
assumptions. Within the UV cases, the number of positive p21 cells was lower after treatment
compared to no treatment for both FSM and BSM. As shown in Table VII, either adding BSM or
FSM to UV(-) cells did not increase the p21 ratios. Furthermore, adding BSM and FSM
decreased the p21 ratio after UV treatment. BSM and FSM decreased p21 levels by 51% and
21.6% respectively. BSM exhibited a significant difference (p-value 0.0004). Although Tukey
HSD pairwise comparisons did not indicate significance for FSM because of the low sample size,
the trends are promising and would most likely demonstrate statistical significance given more
replicates.
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Table VII: Averages for All Treatments Demonstrating Trends
Treatment

BSM (-)
UV (-)
BSM (+)
UV (-)
BSM (-)
UV (+)
BSM (+)
UV (+)
FSM (-)
UV (-)
FSM (+)
UV (-)
FSM (-)
UV (+)
FSM (+)
UV (+)

Average (ratio of p21
positive nuclei to total
nuclei)
0.18

SE

0.0125

0.13

0.0345

0.39

0.075

0.19

0.05

0.18

0.05

0.12

0.0419

0.37

0.0373

0.29

0.0358

4.6.3 Discussion
Although no significant differences were observed between FSM treatments, data
suggests that FSM provides similar photoprotection to UVB exposed KRTs while not inducing
cytotoxic effects. FSM decreased p21 levels by 21.6% compared to the no FSM control.
Similarly, BSM decreased p21 levels by 51% compared to the control, which was statistically
significant.
The lack of significance for FSM and the smaller decrease in p21 ratio could be due to
concentration discrepancies between FSM and BSM. Based on the molecular weight of bovine
milk SM on the Avanti Polar Lipids website, the 0.1% BSM is equivalent to a 1.3 mM
concentration [61]. Thus, the concentrations of FSM and BSM are not equivalent and the FSM
concentration is significantly lower, possibly contributing to the reduced levels in photoprotection
compared to BSM. Further research is needed to reconcile the concentration differences and
optimize the concentration of FSM to yield maximum levels of p21 photoprotection.
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4.7 FSM with Nile Red
4.7.1 Summary and Objectives
Nile red was introduced as a general lipid stain with a purpose to co-stain FSM in order
to help with characterization. Colocalization of FSM with another stain could potentially help
with identification (i.e. if the fluorescent signal is SM, if fluorescent SM has been degraded to
ceramide, or if the signal is freely floating fluorescence). Specifically, FSM signal colocalization
with Nile red would suggest whether the signal was attached to a general lipid (SM, ceramide, or
another metabolite) or just a freely floating probe.
The goal of this experiment was to determine the appropriateness of Nile red as a general
lipid stain for colocalization with FSM. FSM was incubated with cells for 1 hour then removed,
washed once with PBS, then fixed. 200µL of 5µM/mL Nile red was introduced to cells for 15
minutes, then washed off. A nuclei counterstain was also performed.
4.7.2 Results
As Figure 38 demonstrates, the Nile red stain was robust with a high signal to noise ratio
and yielded an intense signal throughout the entire cell. Figures 38A-D represent Nile red and
FSM dual staining while Figures 38E-H correspond to cells only stained with Nile red (no
exogenous FSM incubation).
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Figure 38: Nile Red Representative Images. A-D Nile Red and FSM Dual Staining (100x
objective) (A) Merge of Nile Red, FSM, and Hoechst. (B) Hoechst, (C) FSM, (D) Nile Red. E-H
Nile Red Only (100x objective) (E) Merge, (F) Hoechst, (G) AF 488 channel (no FSM), (H) Nile
Red. Some bleed through was observed from Nile red into the AF488 channel. With the addition
of exogenous FSM, the brightness of the Nile red increased in (D) compared to (H).

Visual comparison between the two Nile red images (Figure 38D and 38H) indicate that
the dual stain with exogenous FSM yielded a brighter Nile red general lipid stain. This suggests
Nile red was successful in demonstrating the increase in total cellular lipid content that occurs
when exogenous FSM is introduced to a cell. However, some slight bleed through was observed
in Figure 38G, most likely due to the bright Nile red signal and spectral overlap between the AF
488 and AF 594 filters used to detect FSM and Nile red respectively.
4.7.3 Discussion
Nile red proved to be a robust, bright stain with high signal to noise ratio. Furthermore, the
Nile red brightness increased after FSM incorporation, suggesting it is sensitive enough to detect
an increase in intracellular lipid content. However, the applications for Nile red are limited
because it is a general lipid stain and not specific to either ceramide or lysenin. Ideally, a stain
that only binds to endogenous SM or ceramide would provide a better way to identify FSM
identity with colocalization quantification. Nile red was removed from future protocols, and
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optimization was conducted on two new immunofluorescence stains, lysenin and ceramide, to
quantify natural endogenous levels of sphingomyelin and ceramide and assess how exogenous
introduction of FSM affects intracellular localization and relative abundance.
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4.8 Lysenin Stain Optimization
4.8.1 Summary and Objectives
Lysenin is a novel probe that has been recently developed for fluorescence detection of
endogenous cellular SM. Lysenin, is a 41-kDa protein obtained from purified coelomic fluid of
the earthworm Eisenia foetida that binds selectively to SM [64]. Recent work has used lysenin
and FSM to mark plasma membrane lipid rafts [65]. Building off of past research, a lysenin
immunofluorescence protocol for this thesis was developed based on concentrations in published
literature [64]. Immunofluorescence staining generally involves incubating the sample in the
lysenin protein, washing off residual, incubating with a primary antibody against the lysenin
protein, washing off residual primary, subsequently introducing a secondary against the species of
the primary antibody, then washing and imaging [64] . A blocking buffer is also introduced to
prevent non-specific binding of the lysenin protein, primary antibody, and secondary antibody
[64].
The goals of these lysenin optimization studies were to identify the optimal lysenin,
primary antibody, and secondary antibody in order to reduce non-specific binding while obtaining
a high signal to noise ratio. Three experiments were conducted to vary the blocking, lysenin
concentration, primary concentration, and stain incubation times. Secondary concentration
remained at a consistent concentration and incubation time throughout all experiments. The
following results section includes a chart of experimental factors corresponding to each
optimization step followed by images.
4.8.2 Results
Table VIII includes the experimental variables tested for in the first optimization study.
Both the lysenin protein and primary antibody concentrations were varied while incubation time
and blocking remained consistent. First, fixed 8-well plates were blocked with 2% BSA in PBS
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overnight, then lysenin protein (at a concentration of 1µg/mL or 3µg/mL) was incubated with
cells for 2 hours. Anti-lysenin primary antibody was subsequently introduced at dilutions of
1/1000, 1/500, or 1/300 in PBS for 9 hours. Finally, a secondary antibody was added at a 1/300
concentration in PBS for 1 hour and a Hoechst counterstain was performed. Thorough washing
steps with PBS were added between each staining step. Table VIII also indicates the controls
performed in the study, to assess whether non-specific binding or bleed through is a common
occurrence. In the table, “X” denotes the indicated procedure was performed and “N/A” means
that particular step was skipped.
Table VIII: Optimization 1: Pilot Study
IF Stain
Concentration
Blocking (B)
2% BSA in PBS
Lysenin (L)
1µg/mL or 3 µg/mL
Anti-Lysenin Primary Ab (1)
1/1000, 1/500, 1/300
Secondary (2)
1/300
Hoechst (H)
0.05%
Control Blocking
Lysenin
Primary
H
X
N/A
N/A
H+1
X
N/A
X (1/300, 9hr)
H+1+2
X
N/A
X (1/300, 9hr)
H+L+1
X
X (1µg/mL, 2hr)
X (1/300, 9hr)
H+L+2
X
X (1µg/mL, 2hr)
N/A

Incubation Time
Overnight
2 hr
9 hr
1 hr
15 min
Secondary
Hoechst
N/A
X
X (1/300, 1hr)
X
X (1/300, 1hr)
X
N/A
X
X (1/300, 1hr)
X

Controls ensure that the fluorescence observed in the experimental condition (H+L+1+2)
is truly an indicator of endogenous sphingomyelin levels and not a result of random binding or
fluorescence by lysenin, primary, or secondary antibodies. The roles of the H, H+1, and H+L+1
controls were to confirm that Hoechst does not bleed through into channels of interest and
singular primary and lysenin are not demonstrating fluorescence when they should not (because
the secondary fluorescence tag is not introduced in these controls). Furthermore, the role of
H+1+2 and H+L+2 controls are to test for non-specific binding. If fluorescence is observed in the
H+1+2 case, this means primary antibody is binding to non-specific regions of the cell even
though lysenin protein is not present. Similarly, if the H+L+2 controls yield fluorescence, the
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secondary antibody is non-specifically binding to the lysenin protein and other regions of the cell
even when the primary antibody against lysenin is not present. Figure 39 includes unsatisfactory
control images for H+1+2 and H+L+2.

A

D

B

C

E

F

Figure 39: Control Images. (A-C) H+1+2 demonstrating non-specific primary binding (60x
objective). (A) Merge, (B) DAPI, (C) AF 488. (D-F) H+L+2 demonstrating slight non-specific
secondary fluorescence (60x objective). (D) Merge, (E) DAPI, (F) AF 488.

An important takeaway from the images was that bright non-specific primary binding
was observed in the H+1+2 case, meaning fluorescence was still observed even when lysenin, the
protein that binds to sphingomyelin directly, was not present. This means the primary was
binding randomly to locations in a cell. Further optimization was needed to attenuate the nonspecific primary binding in the H+1+2 case.
Figure 40 includes images of the experimental images with all components of the staining
procedure (H+L+1+2). Lysenin and primary concentration were varied and overall image quality
was assessed.
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Left and Right:
Lysenin 1µg/mL (2 hours)
Primary 1/1000 (9 hours)

Left and Right:
Lysenin 1µg/mL (2 hours)
Primary 1/500 (9 hours)

Left: Lysenin 1µg/mL (2 hours)
Primary: 1/300 (9 hours)
Right: Lysenin 3µg/mL (2 hours)
Primary: 1/300 (9 hours)

Figure 40: Experimental H+L+1+2 Images. (A-B) Two representative merge images of lysenin
(1µg/mL) and primary (1/1000). (C-D) Two representative merge images of lysenin (1µg/mL)
and primary (1/500). (E) Representative merge image of lysenin (1µg/mL) and primary (1/300).
(F) Representative merge image of lysenin (3µg/mL) and primary (1/300). 60x objective.
The figure demonstrates that bright staining and slight image oversaturation was
observed for cells stained with 1/300 diluted primary and/or 3µg/mL lysenin protein (Figures 40E
and 40G). 1µg/mL lysenin with 1/1000 primary yieded distinct plasma membrane staining
(Figures 40A-B). Finally, the 1µg/mL lysenin with 1/500 resulted in image brightness between
the two extremes.
After this initial experiment, it was decided to progress with a 1ug/mL concentration of
Lysenin and 1/500 primary dilution for 9 hours because the images matched observed staining
morphology in published literature (bright plasma membrane staining) [65]. However, a
subsequent experiment with the previously chosen settings still demonstrated significant nonspecific binding in the controls. Therefore, the primary incubation time was reduced to 1 hour.
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The objective for reducing the primary incubation times was to decrease the saturation of primary
and decrease the likelihood of non-specific binding. A more concentrated blocking buffer, 4%
BSA in PBS/4% Goat Serum, was also introduced to the cells in a second optimization
experiment with variables highlighted in Table IX. The role of the blocking buffer was to more
thoroughly block free non-specific antigen sites. The goal of the following second optimization
was to compare 1/500 and 1/1000 primary dilutions in order to choose the concentration with the
least non-specific binding in the H+1+2 control.
Table IX: Optimization 2: Comparison of Primary Concentrations
IF Stain

Concentration

Blocking (B)
Lysenin (L)
Anti-Lysenin Primary Ab (1)
Secondary (2)
Hoechst (H)
Control
Blocking
H+1+2
X

4% BSA in PBS/4% Goat Serum
1ug/mL
1/500
1/1000
1/300
0.05%
Lysenin
Primary
Secondary
N/A
X (1/300, 9hr) X (1/300, 1hr)

Incubation Time
Overnight
2 hr
1 hr
9 hr
1 hr
15 min
Hoechst
X

Figure 41 includes representative images of H+1+2 controls for both 1/1000 and 1/500
dilution of primary. However, both primary concentrations still exhibited slight non-specific
fluorescence. Therefore, in the final optimization experiment, additional blocking buffer recipes
were tested (Table X).
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Figure 41: 1/1000 versus 1/500 Primary Dilution Comparison. (A) H+1+2 merge with primary
(1/1000). (B) H+1+2 merge with primary (1/500). Insets zoomed-in views of (A) and (B) are
included in the right panel. 100x objective.

Buffers included the previously tested 4% BSA in PBS/4% Goat Serum, but the mild
detergent Tween-20, was also introduced to the blocking buffer and washing solutions to help
prevent further non-specific binding by more efficiently washing off weakly adherent bonds
between the primary and random binding sites. Finally, a 4% nonfat milk powder in PBS/4% Goat
Serum was introduced as an alternative blocking solution.
Table X: Optimization 3: Blocking Buffer
IF Stain

Concentration

Blocking (B)

4% BSA in PBS/4% Goat Serum
4% BSA in PBS/4% Goat Serum + 0.05% PBS-Tween
4% Milk in PBS/4% Goat Serum + 0.05% PBS-Tween
1ug/mL
1/1000 in Blocking

Lysenin (L)
Anti-Lysenin
Primary Ab (1)
Secondary (2)
Hoechst (H)
Control
Blocking
H+1+2
X
H+L+2

X

1/300 in PBS
0.05% in PBS
Lysenin
Primary
X (1/300,
9hr)
X (1ug/mL,
2hr)
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Incubation
Time
Overnight

2 hr
1 hr

Secondary
X (1/300, 1hr)

1 hr
15 min
Hoechst
X

X (1/300, 1hr)

X

A
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D

Figure 42: Blocking Buffer Optimization Non-Specific Binding for H+1+2 Control. (A)
4%BSA/Goat, (B) 4%BSA/Goat+PBS-Tween, (C) 4%Milk/Goat+PBS-Tween, (D) No Blocking.
100x objective.

Figure 42 includes representative control image results of the final blocking buffer
optimization. Qualitatively, all three blocking buffers reduced the fluorescence observed in the
blocking conditions and yielded relatively low green fluorescence signal. Ultimately,
4%BSA/Goat+PBS-Tween was chosen for the final, optimized blocking buffer because the BSA
and goat serum are more characterized than milk. Although some slight fluorescence was
observed in all images (most apparent in the Figure 42A-D insets), the signal was deemed
negligible and blocking was determined to be sufficient. Lab resources and time were directed
towards further characterizing the stain in dual experiments.
Finally, Figure 43 includes representative images of experimental H+L+1+2 treatments.
The use of blocking and reducing primary incubations did not significantly affect staining
efficiency.
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Primary Optimization
Left: Primary 1/1000 (1 hour)
Right: Primary 1/1000 (9 hours)

Blocking Optimization
Left: Blocking 4% BSA/Goat in PBS
Right: Blocking 4% BSA/4% Goat in PBS-Tween
Lysenin 1µg/mL (2 hours)
Primary 1/1000 (9 hours)

Blocking Optimization
Left: Blocking 4% Milk/4% Goat in PBS-Tween
Right: No blocking
Lysenin 1µg/mL (2 hours)
Primary 1/1000 (9 hours)

Figure 43: H+L+1+2 Staining Efficiency Comparisons During Optimization Steps. (A-B)
1/1000 Primary optimization comparison demonstrating incubating for 1 hour. (A) results in a
similar staining efficiency as the 9 hour incubation (B). (C-F) Blocking optimization images (60x
objective) demonstrating that all blocking varieties yielded similar images. 100x objective.

Staining efficiency did not seem to change when the primary incubation time was
reduced from 9 hours to 1 hour (Figure 43A, B). Furthermore, keeping the lysenin and primary
concentrations consistent, and changing the blocking variety did not yield remarkable differences
in image quality. The characteristic bright plasma membrane with some intracellular expression
was observed in all images. However, some heterogeneous lysenin staining among cells within
the same images exists. This inconsistency has been cited in literature and is hypothesized to be a
result of replicative cell senescence; KRTs from a higher passage number (P10) exhibit lower
levels of lysenin staining compared to lower passage number (P4) cells [65]. Although cells with
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a relatively low passage number were used (<P5) in all experiments, cell-to-cell variation could
contribute to the observed heterogeneity.
4.8.3 Discussion
After extensive optimization experiments, the final lysenin staining parameters were
optimized as the following in order to yield the best quality image (Table XI). These
immunofluorescence staining parameters were utilized for subsequent dual staining with FSM.
Table XI: Final Lysenin Staining Parameters
IF Stain
Blocking (B)
Lysenin (L)
Anti-Lysenin Primary Ab (1)
Secondary (2)
Hoechst (H)

Concentration
4% BSA in PBS/4% Goat Serum + 0.05%
PBS-Tween
1ug/mL
1/1000 in Blocking Solution
1/300 in PBS
0.05% in PBS

Incubation Time
Overnight
2 hr
1 hr
1 hr
15 minutes

The lysenin stain appears to mainly concentrate in the plasma membrane with some
intracellular pockets of fluorescence. Although some very slight non-specific secondary binding
was observed, the blocking capabilities of 4%BSA/Goat+PBS-Tween was deemed sufficient.
Some heterogeneity was also observed among cells within the same image. These observations
were consistent among all staining optimization stages and are cited in published literature to be a
result of cellular senescence [65]. To confirm that cell senescence is leading to differences in
lysenin staining, a cell division marker or proliferation assessment like alamarBlue® could be
correlated with lysenin staining.
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4.9 Ceramide Stain Optimization
4.9.1 Summary and Objectives
The goals of these ceramide optimization studies were to identify the optimal ceramide
primary antibody and secondary antibody concentration in order to reduce non-specific binding
while obtaining a high signal to noise ratio. Three experiments were conducted to vary the
blocking, primary concentration, and stain incubation times. Similar to the lysenin experiments,
secondary concentration remained at a consistent concentration and incubation time throughout
all experiments. The following results section includes a chart of experimental factors
corresponding to each optimization step followed by images.
4.9.2 Results
Table XII includes the experimental variables tested in the first optimization study. The
primary antibody concentrations were varied while incubation time and blocking remained
consistent. First, fixed 8-well plates were blocked with 2% BSA in PBS overnight, then anticeramide primary antibody was subsequently introduced at dilutions of 1/200 or 1/300 in PBS for
1 hour or 9 hours. Finally, a secondary antibody was added at a 1/300 concentration in PBS for 1
hour and a Hoechst counterstain was performed. Thorough washing steps with PBS were added
between each staining step. Table XII also indicates the controls performed in the study, to assess
whether non-specific binding or bleed through is a common occurrence. In the table, “X” denotes
the indicated procedure was performed and “N/A” means that particular step was skipped.
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Table XII: Optimization 1: Primary and Controls
IF Stain
Concentration
Blocking (B)
2% BSA in PBS/2% Goat
Anti-Ceramide Primary Ab (1)
1/200, 1/300
Secondary (2)
1/300
Hoechst (H)
0.05%
Control
Blocking
Lysenin
Primary
H
X
N/A
N/A
H+1
X
N/A
X (1/300, 9hr)
H+2
X
X (1ug/mL, 2hr)
N/A

Incubation Time
Overnight
1 hr, 9 hr
1 hr
15 min
Secondary
Hoechst
N/A
X
X (1/300, 1hr)
X
X (1/300, 1hr)
X

Figure 44 includes representative images of the controls H+2 (Figure 44A) and H+1
(Figure 44B). The ceramide was conjugated with an AF 647 secondary and appears as white in all
subsequent images. Some non-specific secondary binding was observed in the H+2 control,
meaning secondary antibody was randomly binding to locations in a cell instead of selectively
binding to just the ceramide primary antibody. No AF 647 ceramide channel fluorescence was
observed in the H+1 control.

A

B

Figure 44: Control Merged Images with DAPI. (A) H+2 control exhibits non-specific
secondary binding, (B) H+1 control shows no random, unattributable fluorescence of the primary
or Hoechst into the AF 647 ceramide channel. 100x objective.

Figure 45 includes representative images of H+1+2 experimental images for the four
different treatments (1/200 for 1 hour, 1/200 for 9 hours, 1/300 for 1 hour, 1/300 for 9 hours).
Within each well, heterogeneous staining was observed. Some cells exhibited diffuse, even
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cytoplasmic staining (e.g. Figure 45C and 45D, while others had bright, uneven pockets or
ceramide expression (e.g. Figure 45B).
A

B

C

D

E

F

G

H

Primary: 1/200 (1 hour)

Primary: 1/200 (9 hours)

Primary: 1/300 (1 hour)

Primary: 1/300 (9 hours)

Figure 45: Experimental H+1+2 Images. (A-B) Two representative merge images of primary
(1/200) for 1 hour. (C-D) Two representative merge images of primary (1/200) and 9 hours. (E-F)
Two representative merge image of primary (1/300) for 1 hour. (G-H) Two representative merge
image of primary (1/300) for 9 hours. Within each treatment, inconsistent ceramide results were
observed. Some cells had diffuse ceramide staining, while others exhibited pockets of intense,
bright staining. 100x objective.
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Moving forward, the 1/300 primary concentration for 9 hours was selected because no
differences in signal brightness was observed between the concentration variables, and 1/300
conserves more reagent. Furthermore, 9 hours was chosen as the incubation timepoint because the
image results suggested the cells were stained more evenly and consistently than the 1 hour
staining treatment (Figure 45C versus 45A and Figure 45G versus 45E). Incubating for a longer
time period allows more stain to penetrate the cell and potentially reduces heterogeneous staining
occurrences. In the second follow-up optimization study, more blocking buffer variants (4% Goat
in PBS, 4% BSA in PBS, and 4% BSA/4% Goat) were tested to reduce the non-specific
secondary binding observed in the H+2 control (Table XIII).
Table XIII: Blocking to Reduce Non-Specific Secondary Binding
IF Stain
Blocking (B)

Concentration
4% Goat in PBS
4% BSA in PBS
4% BSA/4% Goat
Anti-Ceramide Primary Ab (1)
1/300
Secondary (2)
1/300
Hoechst (H)
0.05%
Control
Blocking
Lysenin
Primary
H
X
H+1
X
X (1/300, 9hr)
H+2
X
X (1ug/mL, 2hr)

Incubation Time
Overnight

9 hr
1 hr
15 min
Secondary
Hoechst
X
X (1/300, 1hr)
X
X (1/300, 1hr)
X

Figure 46: Control H+2 with 4% BSA/4% Goat Serum Blocking Merge Image with DAPI.
No non-specific secondary staining is observed. 100x objective.
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Figure 46 depicts an image of a successful control with the 4% BSA/4% Goat Serum
Blocking solution. In the last optimization experiment, primary ceramide antibody 1/300 and
1/400 dilution concentrations were compared to further optimize the primary concentration and
potentially save more reagent. Table XIV lists all other experimental factors and controls. Only
primary concentration was modified.
Table XIV: Further Reduction in Primary Concentration
IF Stain
Blocking (B)
Anti-Ceramide Primary Ab (1)
Secondary (2)
Hoechst (H)
Control
Blocking
H
X
H+1
X
H+2
X

Concentration
4% BSA/4% Goat
1/300
1/400
1/300
0.05%
Lysenin
Primary
N/A
N/A
N/A
X (1/300, 9hr)
X (1ug/mL, 2hr)
N/A

Incubation Time
Overnight
9 hr
1 hr
15 min
Secondary
Hoechst
N/A
X
X (1/300, 1hr)
X
X (1/300, 1hr)
X

Figure 47 demonstrates that no difference in ceramide stain brightness or morphology
was observed between the 1/300 and 1/400 primary concentrations. Both conditions yielded
heterogeneous images with diffuse cytoplasmic staining in some images (Figure 47A, C) and
patchy staining in others (Figure 47B, D). The 1/400 dilution was selected as the final ceramide
concentration in order to conserve reagent and no difference was observed between 1/400 and the
higher concentration.
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Figure 47: 1/300 versus 1/400 Ceramide Primary Comparison. (A)1/300 dilution (60x
objective) demonstrating diffuse staining. (B) 1/300 dilution (40x objective) with patchy staining.
(C) 1/400 dilution (60x objective) with diffuse staining. (D) 1/400 dilution (60x objective) with
patchy staining. The ceramide stain again displayed inconsistent cytoplasmic expression.

4.9.3 Discussion
After several optimization experiments, the final ceramide staining parameters were
optimized as indicated in Table XV in order to yield the best quality image:
Table XV: Optimized Ceramide Immunofluorescence Parameters
IF Stain
Blocking (B)
Anti-Ceramide Primary Ab (1)
Secondary (2)
Hoechst (H)

Concentration
4% BSA in PBS/4% Goat Serum
1/400 in Blocking Solution
1/300 in PBS
0.05% in PBS

Incubation Time
Overnight
1 hr
1 hr
15 minutes

These parameters will be utilized for subsequent dual staining with FSM and lysenin. The
ceramide stained cells also demonstrated heterogeneous staining morphologies which was
observed despite varying blocking, primary concentrations, and primary incubation time. The
reason for the inconsistent staining is unknown at this time, but could be a result of the replicative
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senescence hypothesis cited in the lysenin optimization studies [65]. In addition, few research
groups employ immunofluorescence to stain ceramide, therefore a deficit of direct image
comparisons exists. The localized pockets of inconsistently stained cells within the same well
could indicate some biological or regional cell signaling effecting ceramide concentration in a
cell. Senescence or proliferation markers could be correlated with ceramide to visualize any
staining patterns. Further investigation into the inconsistency will be directed to future work for
the lab, outside the scope of this thesis.
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4.10 Dual Lysenin, Ceramide, and FSM Staining
4.10.1 Summary and Objectives
Dual immunofluorescence staining was performed with two main experiments focused
first on exploratory qualitative assessment, and second, on quantitative fluorescence distributions
of FSM, lysenin, and ceramide together. The goal of this first dual stain experiment study was
mainly proof-of-concept to determine whether dual immunofluorescence staining of FSM treated
cells with both lysenin and ceramide was possible. Dual staining with lysenin and ceramide
immunofluorescence is novel and currently no published primary literature characterizes how
ceramide and endogenous SM levels fluctuate in a cell after continuous incubations with
exogenous FSM using immunofluorescence and imaging. Being able to visualize intracellular
distributions of endogenous SM, ceramide, and FSM in a cell could potentially elucidate the
cell’s response to exogenous SM treatments. Optimization of the dual staining protocol is
warranted for future UV experiments to determine how lysenin, ceramide, and FSM change with
UV perturbation.
Given the time and resources available, only one exploratory experiment was performed
prior to the main quantitative fluorescence trafficking study, and the optimized lysenin and
ceramide protocols were used. 8-well plates with monolayers of KRTs were independently
incubated with FSM at 370C for 24 hours. Immediately after treatment, cells were gently washed
once with PBS then fixed with 3.75% PFA. Using the previously optimized immunofluorescence
protocols for lysenin and ceramide, FSM treated cells were stained individually with lysenin and
ceramide, then dual stained with both. Individual immunofluorescence followed previously
established protocol. For the dual staining, plates were again blocked overnight at 40C with 4%
BSA/4% Goat diluted in PBS-Tween. Next, the lysenin protein was incubated for 2 hours,
washed, and followed by the lysenin primary antibody for 1 hour. Then the ceramide antibody
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was incubated for 9 hours, followed by simultaneous secondary incubations (AF 647 goat antimouse and AF 594 goat anti-rabbit) introduced to the cells at their respective concentrations.
Finally, the nuclei were stained with Hoechst. Sufficient washing steps were performed between
each step in the protocol. During imaging, z-stacks with a 1 µm step size were obtained to
generate a 3D picture of cell staining.
4.10.2 Results
Figure 48 shows representative images for FSM and lysenin staining. Consistent with
previous experiments, lysenin mainly stained the plasma membrane, but some intracellular
fluorescence clusters were observed in a few cells (Figure 48A). Again, some heterogeneity was
observed with some cells brightly stained with lysenin and others not. The FSM signal was still
observed after immunofluorescence and the merge image with lysenin (Figure 48C) suggesting
future colocalization analysis is possible.
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Figure 48: 2D and Maximal Z-Projections of FSM and Lysenin Immunofluorescence. (A)
2D image of AF 594 lysenin channel. Staining mostly concentrates along the plasma membrane
(B) Z-projection of lysenin channel. Adding the 3D component to the images better represents
lysenin distribution. (B) inset shows some regions of concentrated lysenin fluorescence (C)
Merge 2D image AF 594 lysenin with AF 488 FSM. (D) Merge z-projection of lysenin and FSM.
100x objective.

Since z-stacks were obtained for each image, Figure 48B and D show maximal 3D zprojections of the z-stacks. 3D images are useful to show fluorescence distribution across the
entire cell volume. Comparing 2D (Figure 48A) to the 3D projection (Figure 48B), a bright
plasma membrane translates to a bright shell around the nucleus because the projection also
includes plasma membrane on top of the nucleus that was excluded in the 2D confocal image.
The boxed cell zoom inset further demonstrates the utility of these 3D renderings in showing
bright pockets of concentrated lysenin fluorescence not visible with the 2D images. Furthermore,
colocalization of the FSM and lysenin is easier to visualize by the bright orange and yellow shells
surrounding the nucleus.
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Figure 49: 2D and Maximal Z-Projections of FSM and Ceramide Immunofluorescence. (A)
2D image of AF 488 FSM channel. (B) Z-projection of AF 488 FSM channel. (C) 2D image of
AF647 ceramide. (D) Z-projection of AF 647 ceramide channel. 100x objective.

Figure 49 demonstrates that ceramide immunofluorescence staining with FSM was also
successful because both fluorescence signals were visualized in both the AF 488 and AF 647
channels. The z-projection images (Figure 49B and D) are again useful for visualizing holistic
cell fluorescence. For example, the 3D image collects all ceramide fluorescence above the
nucleus (Figure 49D). Entire cell volume images will most likely prove valuable for future
fluorescence distribution and colocalization analysis.
Based on qualitative visual assessment of all images, two staining phenotypes were
observed for both lysenin and ceramide (Figure 50). First, lysenin staining was either
concentrated in the plasma membrane (Figure 50A-C), or intracellular in bright pockets (Figure
50D-F).
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Figure 50: Differential Staining of Lysenin and Ceramide. (A-C) Bright plasma membrane
lysenin staining as demonstrated in the z-projection (A), 2D image (B), and orthogonal view (C)
which shows distinct fluorescence far from the nucleus (white arrow). (D-F) Bright lysenin
staining directly around the nucleus as demonstrated by the z-projection (D), 2D image (E), and
orthogonal view (F) which shows distinct fluorescence only close to the nucleus (white arrow).
(G-I) Distinct plasma membrane and intracellular ceramide staining as demonstrated in the zprojection (G), 2D image (H), and orthogonal view (I) which shows fluorescence clustered
around the nucleus (white arrow). (J-L) Absence of a definitive ceramide fluorescence signal as
demonstrated in the z-projection (J), 2D image (K), and orthogonal view (L) which only shows a
slight signal above the nucleus (white arrow). 100x objective.

The orthogonal views (Figures 50C&F for lysenin and Figures 50I&L for ceramide)
helped with visualization and confirmed the observations in both 2D slices and z-stacks. In a
similar manner, ceramide also demonstrated two different staining characteristics observed within
each treatment. Ceramide staining either yielded diffuse staining with some concentrated
fluorescence around the nucleus (Figure 50G-I), or pockets towards the edges of the cell with
varying degrees of brightness (Figure 50J-L). It is important to note that some cells within the
same image field of view sometimes completely lacked fluorescence staining.
Finally, Figure 51 includes images of dual immunofluorescence staining for both lysenin,
ceramide, and FSM. With the current protocol, the FSM signal appeared to disintegrate and was
severely degraded (Figure 51A&D). The laser power and sensitivity of the confocal PMT was
manually increased to detect the demonstrated fluorescence levels in Figure 51B&D.
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Figure 51: Z-Projection of FSM, Lysenin, and Ceramide after Dual Immunostaining. (A-C)
60x objective image. (A) FSM demonstrating significant signal degradation, (B) Lysenin, (C)
Ceramide. (D-F) 100x objective. (D) FSM, (E) Lysenin with pocket of weakly stained cells, (F)
Ceramide.

The lysenin and ceramide signals did not seem to change after dual staining. Lysenin was
still heterogeneous, with some bright plasma membrane. Ceramide was either diffuse or
concentrated in pockets. The reason for the FSM signal degradation was unknown and many
factors could have contributed to the signal degradation (i.e. time, extra wash steps, using
excessive detergent). The Tween-20 detergent added to the blocking and wash buffers was
hypothesized to contribute to FSM degradation.
4.10.3 Discussion
Dual immunostaining was successful because all three signals (FSM, lysenin, ceramide)
were visible in the images. However, significant signal degradation of the FSM stain was
observed, warranting future troubleshooting to elucidate the reason.
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4.11 Troubleshooting FSM Degradation Observed after Dual Immunofluorescence
4.11.1 Summary and Objectives
The goal of the following experiment was to formulate a hypothesis for the FSM signal
degradation observed during imaging. Multiple hypotheses can potentially explain this
observation. 1) Time – FSM signal degrades over time when stored in PBS between experiments
prior to imaging, with timepoints ranging from immediately after staining to up to two weeks. 2)
Detergent – introducing extra Tween-20 detergent into the blocking and washing buffers leached
FSM from the cell. 3) Protocol specific – the extra PBS washing steps could slowly remove the
FSM signal. Furthermore, the addition of two antibodies could mask the FSM signal. The reason
for decreased FSM is unknown, but the goal of the following experiment was to assess the effects
of introducing Tween-20 to the blocking buffer and PBS wash. Tween-20 was identified as the
target for the first optimization because its removal from the existing protocol was easier to
implement. Briefly, FSM was introduced to cells at 370C for 1 hour, then the media was washed
once with PBS and fixed. Cells were subsequently permeabilized with Triton X and either
washed with PBS or 0.05% PBS-Tween. A control without permeabilization and washing was
used to assess the extent of photobleaching.
4.11.2 Results
As the images demonstrate in Figure 52, introducing Tween-20 washes to the image
system induced some degradation, as indicated by the reduced green fluorescence brightness in
Figure 52C. The degradation in FSM signal was visibly greater than the Triton X with PBS wash
treatment (Figure 52B). This result suggests that Tween-20 detergent in the blocking buffer and
washing steps could potentially contribute to some signal degradation observed in the dual
immunofluorescence images.
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Figure 52: Signal Degradation from Various Staining Treatments. (A) Control, (B), Triton X
permeabilization with PBS washes, (C) Triton X permeabilization with 0.05% Tween-20 Washes.
100x objective.

4.11.3 Discussion
Although a decrease in signal was observed after adding a 0.05% Tween-20 to PBS wash,
this troubleshooting experiment failed to recapitulate all the other variables in the dual
immunostaining procedure. Tween-20 is merely one piece of the degradation dilemma, because
dual stained FSM images exhibited significantly more photobleaching than what was observed in
this troubleshooting experiment (Figure 53). For example, Figure 53A shows the FSM signal
using the FSM laser power settings employed during 2D fluorescence trafficking experiments
(Table IV). Figure 53B is an image of FSM incubated with cells for 1 hour then immediately
fixed and imaged using the same laser power settings from Figure 53A and all fluorescence
trafficking experiments. Finally, Figure 53C is an image of the same cells from Figure 53B,
except the imaging settings were modified to match the laser power and PMT sensitivities used to
obtain the images in Figure 51A&D (dual immunofluorescence settings Table V). The images
demonstrate that dual immunostaining drastically degrades the FSM signal (lack of signal in
Figure 53A). This means the laser and PMT settings need to be increased in order to detect a
signal (as demonstrated by severe saturation of Figure 53C when Figure 53B was imaged with the
new image settings).
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Figure 53: Additional Signal Degradation Demonstrations. (A) Dual immunofluorescence
FSM channel imaged using trafficking settings. (B) Normal FSM with no extra treatment imaged
using trafficking settings (no dual staining). (C) Same FSM image but with dual
immunofluorescence settings. 100x objective.
Additional explanations for the diminished fluorescence could be FSM degradation in
PBS during storage over time or numerous washing steps during the protocol. Further
troubleshooting to identify the source of FSM degradation is currently being investigated in the
lab but is outside the scope of this thesis. For the final experiment – FSM, lysenin, and ceramide
fluorescence distribution – an increased laser power and PMT sensitivity was consistently used to
image the FSM.
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4.12 Dual Lysenin, Ceramide, and FSM Fluorescence Trafficking
4.12.1 Summary and Objectives
The goal of final dual immunostaining protocol was to quantitively determine if FSM,
lysenin (endogenous SM), and ceramide localization in a cell varied over a spectrum of
continuous incubation times (10 minutes, 1 hour, 2 hour, 12 hour, 24 hour, and control without
exogenous FSM incubation). The same 8-well plates used for FSM fluorescence distribution in
Experiment 4.4 were dual immunostained for both lysenin and ceramide according to previously
established protocol. Four wells (n=4) per treatment (3 images/well) were imaged on the confocal
and z-stacks with 1µm step sizes were obtained using identical laser settings. 2D images were
post-processed in ImageJ using the trafficking and rotation ImageJ and MATLAB programs to
obtain the mean gray values over normalized distances from the nucleus for all three stains. The
ceramide channel was used to create the cytoplasmic ROI which was then applied to the FSM and
lysenin channels. Finally, the area under each curve was calculated using MATLAB CUM
TRAPZ function and plotted. ANOVA and Tukey HSD post-hoc tests were performed on the
area data.
4.12.2 Results
Figure 54 includes representative images of FSM, ceramide, and lysenin after 10 minutes,
1 hour, 2 hour, and 12 hour continuous incubations. The 24 hour and control timepoints were not
analyzed because of high variability among all three stains which made determining each cell
ROI difficult. Two representative images for the 1 hour and 2 hour timepoints are included to
demonstrate ceramide staining inconsistency observed throughout all timepoints. The only
noticeable differences among all the channels was within the lysenin staining. A brighter plasma
membrane fluorescence was observed in the 1 hour cases. Furthermore, in the 2 hour cases, more
intracellular fluorescence around the nucleus was apparent.
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FSM

Lysenin
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10 Min

1 Hour
Example
#1

1 Hour
Example
#2

2 Hour
Example
#1

2 Hour
Example
#2

12 Hour

Figure 54: Representative Dual Immunofluorescence 2D Images for Various Continuous
FSM Incubation Times. 100x objective.
Two 1 hour and 2 hour examples are provided to demonstrate that the inconsistent
ceramide staining made fluorescence distribution quantification difficult. Because the ceramide
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channel was used to generate the ROI for the program quantification, uneven ceramide
cytoplasmic staining means the automated macro cannot reliably outline the cell, thus introducing
potential bias by only outlining and quantifying cells with a more even cytoplasmic ceramide
fluorescence.
Figures 55 and 56 include fluorescence localization results generated from the 2D
fluorescence distribution program. The results for FSM, lysenin, and ceramide after different
continuous incubation times are presented in separate graphs. Comparisons between stains (in
terms of brightness) cannot be made because the signal intensity for one stain (i.e. FSM) is not
directly related or proportional to the signal intensity of another stain (i.e. ceramide). This is due
to a variety of factors including different dilutions of secondary antibodies were used for
immunofluorescence. It is interesting to note that a peak close to the plasma membrane was
observed in the 1 hour (Figure 55B black arrow). This correlates with the 1 hour images which
displayed a bright plasma membrane staining (Figure 54). Furthermore, the 2 hour lysenin
timepoint fluorescence distribution curve exhibited a spike in fluorescence close to the nucleus
(Figure 55B red arrow). The data also appears to correlate with images (Figure 54). No other
differences in fluorescence distribution curves for FSM, lysenin, and ceramide were observed.
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Figure 55: FSM, Lysenin, and Ceramide Fluorescence Distributions over Variable
Continuous Incubation Times (n=4 wells). (A) FSM, (B) Lysenin, (C) Ceramide.

*#
*

Figure 56: Relative Amounts of Ceramide, FSM, and Lysenin. No significant differences
among ceramide and FSM timepoints. # significant difference from global mean. * significant
difference from each other. Standard error bars are represented.
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Tukey HSD pairwise comparisons were only employed for comparisons within each stain
(Figure 56). Appendix B includes results of statistical assumptions. No significant differences
were observed among FSM and ceramide timepoints. However, for the lysenin stain, the 2 hour
(M 53.9k, SE 3.64k summative mean gray value) was significantly greater than the global mean
(M 41.53k, SE 4.3k) (p 0.0083 increase of 30%) and 10 minutes (M 33.7k, SE 3.51k) (p 0.0366
increase of 60%).
4.12.3 Discussion
After immunofluorescence staining and trafficking analysis, results demonstrated that no
significant differences existed within the individual ceramide and FSM stains for 10 min, 1 hour,
2 hour and 12 hour incubation timepoints. Furthermore, FSM data mirrored results from the prior
FSM trafficking experiment, even though signal degradation was observed. Within the lysenin
stain, the 2 hour was significantly greater than the 10 minute incubation (60% increase). The
fluorescence distribution graphs for lysenin also mirrored the intense plasma membrane staining
in the 1 hour and predominant intracellular fluorescence in the 2 hour.
Despite the significant difference between lysenin 2 hour and 10 minutes, the biological
significance is unknown and could be attributed to measurement error or variability within the
system. The lysenin fluctuations suggest endogenous SM levels are changing in a cell, but
differences in FSM intensity alone were not detectable with the current analysis method. The
inability to detect significant differences in the ceramide stain could also be a result of
heterogeneous staining that biased or diluted observable differences. The variability was most
apparent in the 24 hour and control plates making fluorescence distribution analysis impossible.
More replicates are needed to obtain scientifically relevant data.
Future steps include troubleshooting the reason for inconsistent staining, and either
developing a novel analysis technique to reduce bias or analyzing diffuse and patchy ceramide
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cells separately. Another improvement is analyzing fluorescence distribution in 3D to account for
signal above/below the nucleus. Finally, more experiments are needed to isolate the cause for the
FSM signal degradation. Although Tween-20 was removed from all washes and blocking buffers,
degradation was still observed, which suggests the problem is multifaceted and dependent on
multiple variables. Instead of quantifying dual immunofluorescence images, the colocalization
analysis could be implemented in FSM cells stained either with lysenin and ceramide
individually; taking a step back reduces variability and simplifies the complex staining protocol.
Before developing an accurate colocalization method, the stains need to be further
optimized to reduce variability within ceramide and isolate the cause for FSM degradation.
Overall, the experiment is promising and demonstrates that dual immunostaining is possible, with
more optimization in the future. Eventually, the improved staining protocol could be applied to
irradiated cells in order to assess post-UV lysenin and ceramide fluctuations.
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4.13 Spheroid Trial 1: KRTs and 3T3 Single Culture in Non-Adherent U-Wells
4.13.1 Summary and Objectives
Spheroids prove to be a novel method of 3D culture in order to recapitulate the dynamics
of cell behavior in a microenvironment similar to tissue [69]–[77]. One goal within the Cal Poly
Bio Imaging Lab is to generate a 3D model of physiologically relevant skin to test the BSM and
FSM lipid treatments and assess UV photoprotection. Spheroids could potentially serve as one
solution but require extensive testing to demonstrate the model is physiologically accurate and
equivalent to current 2D monolayers employed in the lab. In general, spheroids can form in a
variety of methods with one being non-adherent static culture [69]–[77]. A binding agent, such as
methylcellulose, is introduced to the cell suspension and mixed before being dispensed into nonadherent 96-well plates [69]–[77]. The well culture surface prevents cell attachment while the
methylcellulose aids in binding among the cells [69]–[77]. After several days of culture, spheroid
formation is usually visible under the whitelight microscope, then various treatment conditions
(i.e. Hoechst nuclei staining and imaging) can be performed on each individual spheroid.
For this thesis, several experiments were conducted on spheroids, the first being proof-ofconcept to assess the ability of 3T3 and KRT cells to form single-culture spheroids in nonadherent culture conditions. 3T3 cells were chosen as a cell type because they were readily
available in lab, possess robust growth characteristics, and proliferate rapidly as an immortalized
cell line. Both 3T3 and KRT cells were cultured under normal conditions, then trypsinized and
suspended in a 2% v/v methylcellulose suspension diluted in 3T3 or KRT media. The appropriate
cell number was suspended in the methylcellulose media to ensure approximately 1000 cells were
seeded per spheroid. 100µL of cell suspension was pipetted into each well of the 96-well plate (at
a seeding density of 1000 cells per spheroid). Spheroids were allowed to grow in their nonadherent condition for about 5 days and morphology was assessed visually under the whitelight
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microscope every two days. At the end of the 5 day culture, each spheroid was aspirated with a
1000µL pipet tip, then placed into a conical tube; about three spheroids were added to each tube.
Spheroids were gently washed once with PBS, fixed for 20 minutes with 3.75% PFA, then
stained with 0.1% Hoechst diluted in PBS for 20 minutes. The working volume of the solutions
added to each conical was 200µL. Finally, spheroids were washed three times with PBS, then
pipetted into 8-well glass coverslip plates for imaging. Spheroids were located on the confocal
then z-stacks with a 1µm step size were obtained from the start of the spheroid (at the glass
coverslip interface) to the limit of working distance for the confocal.
4.13.2 Results
After two days of culture, spheroids in non-adherent U wells were inspected under the
whitelight microscope. While 3T3 spheroids formed a definitive spherical shape (Figure 57A),
KRT spheroids were not visible and only small, less distinct clusters of KRTs were observed
(black arrows in Figure 57B).
A

B

Figure 57: Whitelight Images of 3T3 and KRT Spheroids after 2 Days for Culture. (A) 3T3
cells formed a distinct spheroid. (B) KRT cells failed to form spheroids and instead small clusters
of cells were visible (e.g. black arrow).

Figure 58 includes z-projections of the confocal z-stacks for a representative KRT spheroid
(Figure 58A) and 3T3 spheroid (Figure 58B). The confocal z-stacks mirrored the whitelight images
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in Figure 57. Only small aggregates of KRTs were observed while a distinct spheroid (with
diameter of approximately 200µm) formed in the 3T3 culture.
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Figure 58: Representative Images of KRT and 3T3 Spheroids. (A) KRT cells failed to form
spheroids. (B) 3T3 spheroid. (C) Orthogonal view of 3T3 spheroid showing that the Hoechst dye
did not penetrate into the depth of the spheroid. (D) 2D image of start of z-stack, (E) 2D image of
middle of z-stack, (F) 2D image of end of z-stack demonstrating the lack of Hoechst dye visibility
at the interior core of the spheroid. 40x objective.

Due to the thickness of the spheroid and limited working distance of the 40x confocal
objective, the entire spheroid was not able to be imaged. Figure 58C shows an orthogonal view to
demonstrate that only the tip of the spheroid was imaged. As the z-stack depth increased, the
intensity of the Hoechst stain diminished. Figures 58D-F include representative 2D images of the
spheroid during z-stack sectioning. At the start of the spheroid, bright fluorescence is visible in
the middle of the frame (Figure 58D), then progressively radiates outward as the scan depth
increases (Figures 58E-F).
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Another observation during imaging was that the Hoechst dye failed to penetrate into the
interior of the spheroid. In Figure 58F, a clear lack of Hoechst dye was observed in the center.
4.13.3 Discussion
3T3s, but not KRTs, were able to form robust spheroids, and confocal imaging
demonstrated that the Hoechst dye did not penetrate sufficiently into the interior of the spheroid.
In order to encourage KRTs to form spheroids, it was hypothesized that fibroblasts were needed
to facilitate adhesion. The concentration of methylcellulose and seeding density (among other
factors) could also affect spheroid formation. Therefore, in the subsequent experiment, co-culture
spheroids of 3T3s and KRTs were cultivated for different seeding densities and methylcellulose
concentrations.
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4.14 Spheroid Trial 2: KRT and 3T3 Dual Culture
4.14.1 Summary and Objectives
The goal of the following experiment was to assess whether culturing KRTs with 3T3s
facilitated spheroid formation. Multiple parameters (methylcellulose concentration, total cells per
spheroid, and seeding density ratios) were varied as indicated in Table XVI. Note that the media
composition ratio matched the seeding density ratio (i.e. if cells were mixed 1:1, the media for the
spheroid was also mixed 1:1). In order to distinguish the KRTs from 3T3s, CellTracker Red was
incubated with the KRTs to stain their cytoplasm. All cells were stained with Hoechst.
Table XVI: Experimental Parameters Varied for Dual 3T3 KRT Spheroids
Experimental Parameter
Methylcellulose Concentration

Value
20% v/v
40% v/v
1,000
5,000
1:1
2:1
1:2
1:1
2:1
1:2
5 Days

Total Cells
Seeding Densities Ratio (3T3:KRT)

Media Composition Ratio (3T3 media: KRT
media) Matched seeding density ratio
Culture Time

4.14.2 Results
Visual inspection under the whiltelight microscope after 3 days of culture suggested that
spheroids formed in the dual culture cases with 3T3s and KRTs (Figure 59A&B). No spheroids
were generated in the KRT only culture (Figure 59C). Furthermore, in the dual culture, some
satellite colonies or small aggregates of cells formed around the main spheroid (black arrow).

127

A

C

B

Figure 59: Whitelight Images after 3 Days of Culture. (A) 2:1 40%. (B) 1:1 40%. (C) KRT
only 40%. Satellite colonies of KRTs are observed surrounding the main spheroid (arrow). No
spheroids formed in the KRT only culture.

Figure 60 includes representative images of dual spheroids of different parameters. The
bright red fluorescence with blue nuclei stain corresponded to KRTs stained with CellTracker red
cytoplasmic stain. Hoechst nuclei without CellTracker staining distinguished 3T3 from KRT
cells. The representative images demonstrate that KRTs were present in the spheroids, but the
degree to which they integrated into the spheroid varied. In most cases, the KRTs did not evenly
distribute and instead formed satellite colonies (as demonstrated by the intense red fluorescence
clusters).
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Figure 60: Z-Projections of Confocal Spheroid Z-Stacks. (A) 3T3: KRT at 1:1 ratio with 1,000
cells total and 40% methylcellulose (B) 3T3: KRT at 1:1 ratio with 5,000 cells total and 40%,
methylcellulose (C) 3T3: KRT at 2:1 ratio with 5,000 cells and 20% methylcellulose (D) 3T3:
KRT at 2:1 ratio with 5,000 cells total and 40%, methylcellulose (E) 3T3: KRT at 1:2 ratio with
5,000 cells total and 40% methylcellulose. 40x objective.

4.14.3 Discussion
The dual spheroid experiment suggests that 3T3 fibroblasts are needed to encourage KRT
spheroid formation. However, KRT integration was limited and satellite colonies were observed
adjacent to the main 3T3 spheroid. Future steps include repeating this study and investigating
other factors to encourage full KRT incorporation into spheroids. Furthermore, using a more
relevant dermal fibroblast model could potentially encourage KRT spheroid formation.
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4.15 Spheroid Trial 3: Culture with Agarose-coated Flat Bottom Wells with Triton X and
FSM Incorporation
4.15.1 Summary and Objectives
The main goals for this final trial were three-fold. Table XVII summarizes the
experimental parameters used for this third experimental trial. First, flat bottom wells were coated
with agarose to substitute for the more expensive Corning® non-adherent U-well utilized in past
experiments. 96-well flat bottom plates were coated with 200µL to form a meniscus and
nonadherent surface. Approximately 1,000 3T3 cells suspended in 20% v/v methylcellulose were
seeded per 8-well plate and incubated for 5 days.
The second goal was proof-of-concept to determine if FSM fluorescence would be
present after incubation with the spheroids. 5uM FSM solution was introduced to 3T3 spheroids
for 1 hour and 24 hours. Immediately after the incubation, the spheroids were fixed and prepped
for subsequent staining.
Finally, the third goal was to assess whether Triton X permeabilization could encourage
Hoechst penetration into spheroids. Half of the 3T3 spheroids were incubated with 0.1% Triton X
for 20 minutes, then all spheroids were stained with 0.1% Hoechst for 24 hours.
Table XVII: Spheroid Trial 3 Experimental Parameters
Methylcellulose Concentration
Total Cells
Culture Time
Treatment
Permeabilization

20%
750-1000 cells/spheroid
5 Days
5uM FSM for 1 hour or 24 hours
0.1% Triton X 20 minutes
No Triton X
0.1% Hoechst for 24 hours

Staining
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4.15.2 Results
Figure 61 includes white light images of 3T3-methylcellulose solutions seeded onto
agarose coated wells (Figure 61A) and non-agarose coated wells (Figure 61B). Spheroid
formation under agarose conditions was successful. Agarose coating formed a concave meniscus
and simulated the U-well shape of the previously used Corning® plates (Figure 61C).
B

A

C

Figure 61: Agarose is Necessary and Sufficient to Create a Non-Adherent Environment for
Spheroid Formation of 3T3 Cells. (A) Agarose, (B) No Agarose, (C) Agarose Meniscus (black
arrow)
Finally, Figure 62 includes representative images of the spheroids incubated with FSM
then permeabilized with Triton X prior to Hoechst staining. Even with permeabilization, Hoechst
did not penetrate the interior of the spheroids (Figure 62 C&E). Furthermore, the FSM fluorescence
was only observed along the top of the spheroid, independent of the incubation time and Triton X
incubation (Figure 62 F, G, H).
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Figure 62: Orthogonal View of 3D Spheroid with FSM and Triton X. (A) Representative
FSM spheroid z-project. (B) Start of z-stack for representative FSM spheroid. (C) Corresponding
orthogonal view. (D) Middle of z-stack for representative FSM spheroid (E) Corresponding
orthogonal view. (F) FSM 1 hour, no Triton X (G) FSM 24 hours, no Triton X (H) FSM 24 hours,
Triton X. 40x objective.
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4.15.3 Discussion
Results from this final experiment suggest that agarose coating is a sufficient alternative
to Corning® U-well plates in terms of promoting 3T3 spheroid formation. Furthermore, agarose
provides a more cost-effective alternative.
Unfortunately, Triton X incubation did not mitigate the Hoechst penetration
insufficiencies. FSM also failed to penetrate deep into the spheroid and instead collected at the
top of the spheroid regardless of incubation duration. Future steps include running more studies
on the agarose coated wells and investigating other factors responsible for the lack of Hoechst
and FSM penetration into the interior of the spheroids.
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4.16 Spheroid Quantification: Dye Penetration
4.16.1 Summary and Objectives
For the final spheroid experiment, a method was developed to quantify dye penetration
into 3D spheroids. This analysis method could potentially be used for future studies into FSM dye
penetration.
4.16.2 Results
Figure 63 includes multiple images of the process for spheroid depth of penetration
analysis. Each image in the z-stack was thresholded to remove slices without a fluorescence
signal (Figure 63 A&B). A projection of the entire z-stack was used to outline the spheroid
(Figure 63 C). Using the spheroid outline, the 2D fluorescence distribution macro was run on
slices corresponding to the start, 1/10, 2/10, 3/10, 4/10, 5/10, 6/10, 7/10, 8/10, 9/10, and end of
the z-stack. Figures 63D-F show representative images of divisions 1/10, 3/10, and 8/10. Figure
63G is a graphical representation of the fluorescence distributions for each division. Note that
divisions 2/10 and 3/10 have bright staining close to the center, then the fluorescence moves
outward towards the end of the outline as the depth increases. Finally, Figure 64 shows results of
the CUM TRAPZ area under the curve calculations for each image division across all treatments.
The amount of fluorescence peaks at 2/10 divisions then gradually drops as the depth increases.
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Figure 63: Analysis Method for Spheroids. (A) Slice in Spheroid, (B) Binary, (C) Z-projection
with outlines, (D) 1/10 division, (E) 3/10 division, (F) 8/10 division. (G) Graphical representation
of the fluorescence distribution.
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Figure 64: Relative Amount of Hoechst Dye over Normalized Spheroid Depth. Standard error
bars are represented.
Despite a high concentration of Hoechst and 24 hour incubation, the dye failed to
penetrate the interior of the spheroid. Nevertheless, the quantification method can be used to
assess future FSM trafficking in a 3D spheroid model.
4.16.3 Discussion
The described image analysis method provides a way to analyze FSM and Hoechst dye
penetration into spheroids for future work. The data matches visual results from the spheroid
image over varying z-stack depths and demonstrates quantitatively that Hoechst insufficiently
penetrates the spheroid core independent of incubation time and dye concentration.
The results could potentially be a confocal imaging limitation, and it is unknown whether
the result is an artifact of insufficient imaging. For example, the confocal objective working
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distance is not appropriate or the spheroid is too thick to allow sufficient laser penetration for
imaging. Furthermore, it is unknown if cells are even present in the center, or if a necrotic core
formed in each spheroid due to insufficient nutrient diffusion (thus suggesting a reason for the
lack of nuclear staining). Future steps include using multiphoton and conducting histology to
physically section through the spheroids and stain them.
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5. DISCUSSION AND CONCLUSIONS
The following describes the three main goals, implications, limitations, and future steps
from the completed experiments.
Goal 1: Does FSM intracellular trafficking change with varying incubation times, and after
UVB radiation?
a. Subset 1: Characterize FSM in KRT culture during live and fixed cell cultures
using fluorescence confocal imaging
b. Subset 2: Assess the localization of FSM in normal and UVB-stressed KRTs
under varying incubation times
c. Subset 3: Demonstrate functional equivalence of bovine milk SM to its
fluorescent counterpart
The application of Goal 1 was to determine an optimal incubation time by studying FSM
trafficking differences after various continuous incubation times and after UV radiation. First, the
functionality of the 5µM Fluorescent Sphingomyelin (FSM) concentration in a live and fixed
Keratinocyte (KRT) skin cell monolayer using confocal fluorescence microscopy was
demonstrated. Results indicated that a 5µM FSM incubation yielded robust fluorescence and was
able to undergo fixation prior to imaging. Blebbing and both plasma membrane intracellular
staining was observed, consistent with literature [63]. A higher magnification, like the 100X
objective, was deemed more suitable for higher resolution intracellular imaging. Subsequently,
FSM was incubated for various timepoints at 370C and imaged live. Images suggested that FSM
intensity and location does not change significantly with incubation time over 24 hours. Although
live imaging is advantageous for time studies, without the proper equipment to maintain
physiologic temperatures, cell phenotype and FSM trafficking can be affected. In addition, FSM
photobleaching and cell movement was also deemed problematic, necessitating future fixed
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experiments for FSM trafficking quantification. Furthermore, cells were incubated with FSM at
room temperature to demonstrate the FSM endocytic and exocytic temperature dependence and
demonstrate that temperature, along with many other extraneous variables, need to be controlled
in experiments.
To obtain quantifiable data, two experiments were conducted. First, cells were incubated
with FSM for 10 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 12 hour, and 24 hour, fixed
in 3.75% PFA, imaged, then analyzed with a fluorescence distribution macro developed
previously in the research lab. Area under the curve data mirrored the live time study and
demonstrated that intracellular FSM trafficking was independent of the continuous incubation
time.
Second, cells were continuously incubated with FSM for 1 hour or 24 hours, subjected to
UV radiation, and fixed at different timepoints after UV. Area under the fluorescence distribution
curves demonstrated no difference among the 24 hour incubation post-UV timepoints, but some
slight variation for the 1 hour incubation timepoints. In particular, the 12 hour post-UV area
under the curve was significantly greater than 1 hour and 2 hour by approximately 50% and 41%
respectively. In addition, the no UV control was significantly lower (24% decrease) compared to
the 24 hour post-UV timepoint (24% decrease) and 12 hour post-UV timepoint (49.29%
decrease). Across all post-UV timepoints, the 1 hour incubation had a consistently higher average
cytoplasmic mean gray value compared to the 24 hour incubation, with statistical significance for
12 hour and 24 hour post-UV.
The results potentially point towards a shorter timepoint for BSM/FSM incubation prior
to UV (1 hour) and warrant further investigation into the photoprotective effects of a shorter
incubation timepoint. Replication and a larger sample size are both necessary before making
definitive conclusions. In the future, use of 1-well plates (instead of 8-wells) may prove
advantageous to provide a more consistent UV dosage without the plastic division reflecting and
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obstructing UV light. Confocal images could be taken in the center of the well and repeated for
multiple plates, where each plate is treated as an independent unit (instead of each well, as in the
case of this thesis). Replicating with multiple 1-well plates per treatment will ensure complete
independence among treatments and an even UV dosage.
Finally, FSM was deemed functionally equivalent to BSM in terms of p21
photoprotection. FSM decreased p21 levels by 21.6% compared to the no FSM control. Similarly,
BSM decreased p21 levels by 51% compared to the control, which was statistically significant.
The lack of significance could be due to concentration mismatch between the FSM 5µM and
0.1% BSM (a 1.3 mM concentration). In the future, the concentration of FSM should be
optimized by diluting the 1mM stock to yield incremental concentrations of FSM, exposing to
cells for a consistent incubation time, quantifying dosage-dependent p21 effects, then selecting
the concentration that offers the most photoprotection.
The FSM trafficking studies are limited in that a low sample size (n = 4 or 6) was used
for both quantification experiments. The 2D fluorescence distribution analysis could potentially
introduce bias by improperly drawing cell ROIs. In addition, fluctuations in the amount of FSM
added, the positioning of the plate under the UV lamp, or changes in the day-to-day confocal laser
characteristics could all affect data. Additionally, harsh washing of cells before fixation could
remove weakly adherent and damaged cells, thereby skewing data. Finally, it is unknown whether
the measurement system is actually sensitive enough to detect small significant differences in
brightness, and furthermore, what a difference in fluorescence means biologically.
Future work includes more replication, using 1-well plates for experiments, refining the
2D fluorescence distribution analysis, extending analysis to 3D images, reducing the severity of
wash steps, and implementing various controls. First, a SMase enzyme, known to degrade SM,
could be introduced to cells loaded with FSM as a positive control to validate the analysis system.
Subsequent images/analysis could demonstrate how/if FSM intensity degrades after the SMase
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enzyme, and if the current 2D image analysis is sensitive to detect a difference. The SMase
control will help isolate problems with the current analysis. Furthermore, experiments could be
validated with HPTLC, a traditional technique to quantify lipid content. Finally, a 3D analysis
system, similar to the MABLAB code developed by Pike et al., could be used to obtain more
accurate data and encompass FSM plasma membrane expression surrounding the cell [86].
Replication, tight control of extraneous variables, SMase controls, validation with HPTLC, and
3D image analysis are all necessary future steps.
Goal 2: Do endogenous SM and ceramide levels fluctuate with exogenous FSM incubations?
Is it possible to characterize, with fluorescence microscopy, the identity of the observed FSM
signal over time?
a. Subset 1: Develop immunofluorescence staining protocols for both endogenous
SM (lysenin) and endogenous ceramide
b. Subset 2: Characterize how endogenous SM and ceramide levels change with
varying FSM incubation timepoints
For goal 2, immunofluorescence stains were optimized for both endogenous
sphingomyelin (lysenin) and ceramide in order to reduce non-specific binding. The staining
parameters were then implemented in a dual staining protocol with FSM, lysenin, and ceramide
staining to quantify 2D trafficking of the respective stains. Results demonstrated that no
significant differences existed within the individual ceramide and FSM stains for 10 min, 1 hour,
2 hour and 12 hour incubation timepoints. However, within the lysenin stain, the 2 hour was
significantly greater than the 10 minute incubation (60% increase). Despite this difference, the
biological significance is unknown and could be attributed to the aforementioned measurement
and imaging errors. The data could also indicate homeostatic fluctuations in lysenin levels not
visible with just FSM staining alone. However, without validating the sensitivity of the
measurement system with a positive aSMase control, conclusions about biological significance
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cannot be drawn. The results demonstrate that dual immunofluorescence staining is possible and
the images are appropriate for future colocalization experiments to better characterize FSM
metabolism over time.
Future steps include troubleshooting the reason for inconsistent staining and refining the
analysis technique because further optimization is needed before quantifying colocalization of
FSM with lysenin and FSM with ceramide. Senescence or proliferation markers could be
correlated with lysenin and ceramide to assess differences in the state of the cell. In addition,
adopting the previously mentioned MATLAB 3D fluorescence distribution code could account
for differences in the observed heterogeneous ceramide and lysenin staining [86]. Finally, lysenin
could potentially serve as a fluorescence marker for BSM localization in a cell. Studies similar to
FSM could be run in parallel to assess differences in localization between the two SM analogues.
Goal 3: Are cell spheroids a viable platform to move future research from a 2D to 3D model?
a. Subset 1: Develop a method to culture NIH 3T3 immortalized mouse fibroblast
spheroids, for eventual incorporation of KRT cells and FSM
b. Subset 2: Quantify dye penetration over various concentrations and incubation
times
The final goal of this thesis was to provide initial results towards development of a 3D
KRT spheroid model to better recapitulate the dynamics and microenvironment of tissue.
Spheroids were plated with 3T3 fibroblasts and mixed with KRTs in non-adherent U-well plates
from Corning®. KRTs failed to integrate into the spheroid and instead formed satellite
clumps/colonies adjacent to the main spheroid. Agarose coated wells were tested as an alternative
to Corning® non-adherent U-wells. 3T3 spheroids successfully formed in the agarose wells, but
Hoechst dye failed to penetrate even with Triton X permeabilization. Finally, in the last
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experiment, FSM was introduced to the spheroids, and a method to quantify dye penetration was
developed for future studies.
Future work includes developing a more consistent method to handle the spheroids in a
high-throughput manner. Histological (either paraffin or frozen embedded) sections of the
spheroids can be obtained to definitively characterize the spheroid core. Given the difficulty with
handling and sectioning individual spheroids, Gong et al. developed methods for controlling
location and growth of spheroids by manufacturing micro-wells [75]. Ivanov et al. micropatterned
agarose, cultured spheroids into each individual well, then sealed the wells with agarose before
sectioning [76]. Furthermore, Wong et al. embedded spheroids in HistoGel® prior to paraffin
embedding and sectioning [74]. High-throughput spheroid handling techniques and assessment
methodologies are possible but require optimization.
Furthermore, methods to encourage KRT spheroid incorporation need to be developed. A
more relevant dermal fibroblast cell line, instead of 3T3 mouse fibroblasts, should be used to
replicate the work of a few recent research groups [79]. In addition, the use of calcium
supplements in media could encourage skin cell stratification [16], [79] Spheroids can be treated
with the same experimental parameters as the monolayers (including FSM incubation, UV,
immunofluorescence staining, and imaging).
Finally, the use of spheroids as an appropriate tissue engineered skin equivalent needs to
be validated and justified against gold-standard (flat sheet-based culture) and previous lab
methods (2D monolayers). Although 3T3 spheroids were successfully generated, more work is
needed to demonstrate the utility of the model.
In summary, this thesis aimed to expand on past BSM research by clarifying the
mechanism for photoprotection with a fluorescent analogue. FSM was found to yield similar
photoprotection as its BSM counterpart, and FSM intracellular fluorescence distributions were
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independent of continuous incubation time. Future investigation into shorter incubation
timepoints prior to UV is needed, especially considering the observed post-UV fluctuations in
total cellular fluorescence compared to the conventional 24 hour incubation. Furthermore, lysenin
and ceramide immunostaining hold promise for further endogenous sphingolipid studies in
addition to colocalization analysis. Finally, a 3T3 fibroblast spheroid model demonstrated proofof-concept for more relevant 3D skin models. The goal of future research is to ultimately
elucidate the photoprotective potential of sphingomyelin in order to provide a natural alternative
to sunscreen and prevent NMSC incidence in the general population.
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APPENDICES
A. 2D Fluorescence Distribution Codes
The following ImageJ and MATLAB codes were written by Tyler Fraser and Stephanie
Switalski.
FSM Doughnut ROI
//Hoechst/DAPI ROI merge
run("Maximum...", "radius=1");
run("Remove Outliers...", "radius=10 threshold=1 which=Bright");
setOption("BlackBackgroud");
run("Gaussian Blur...", "sigma=1");
run("Make Binary");
run("Erode");
run("Fill Holes");
run("Watershed");
run("Analyze Particles...", "size=70-Infinity circularity=0.50-1.00 exclude include add");
//select and merge ROI
array1 = newArray("0");;
for (i=1;i<roiManager("count");i++){
array1 = Array.concat(array1,i);
Array.print(array1);
}
roiManager("select", array1);
roiManager("Combine");
roiManager("Add");
roiManager("Delete");
run("From ROI Manager");
roiManager("select", 0);
run("Make Inverse");
roiManager("Add");
roiManager("Delete");
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//opens fSM channel
run("Open Next");
//fSM ROI
run("Maximum...", "radius=1");
run("Subtract Background...", "rolling=70");
run("Enhance Contrast...", "saturated=0.1");
run("Gaussian Blur...", "sigma=1");
run("Find Edges");
run("Make Binary");
run("Fill Holes");
run("Dilate");
run("Dilate");
run("Dilate");
run("Fill Holes");
run("Watershed");
run("Analyze Particles...", "size=100-Infinity circularity=0.05-1.00 exclude include add");
run("Revert");
//Select each ROI and 'add' to the inversed combined DAPI channel
for (i=1;i<roiManager("count");i++){
roiManager("Select", newArray(0,1));
roiManager("AND");
roiManager("add");
roiManager("Deselect");
roiManager("Select", 1);
roiManager("Delete");
}
roiManager("Select", 0);
roiManager("Delete"); //deletes the combined DAPI
//Measure doughnuts
roiManager("Deselect");
roiManager("Measure");
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String.copyResults();
selectWindow("Results");
run("Close");
FSM Doughnut ROI Rotation
run("Set Measurements...", "area mean standard min centroid perimeter display redirect=None
decimal=3");
dir = getDirectory("Choose a Directory");
imageTitle=getTitle();
for (d=0;d<roiManager("count");d++){
run ("16-bit");
roiManager("Select", d);
ROIname=getInfo("roi.name");
roiManager("Select", d); //roiManager("Deselect");
roiManager("Measure");
run("Clear Outside");
getVoxelSize(width, height, depth, unit);
X1=getResult("X")/width;
Y1=getResult("Y")/width;
//Draw overlay line
Length=200;
theta=0;
run("Clear Results");
for (i=1;i<61;i++){
//run("Clear Results");
name= " "+theta+"_Degrees";
path=dir+imageTitle+"_Cell_"+d;
radians=theta*(PI/180);
X2=X1+(Length*cos(radians));
Y2=Y1+(Length*sin(radians));
makeLine(X1, Y1, X2, Y2,4);
profile = getProfile();
for (n=0; n<profile.length; n++) {
153

setResult(name, n, profile[n]);
}
updateResults;
theta=theta+6;
}
run("Revert");
saveAs("Results",path+".csv");
}
array1 = newArray("0");;
for (i=1;i<roiManager("count");i++){
array1 = Array.concat(array1,i);
Array.print(array1);
}
roiManager("select", array1);
roiManager("Delete");
close();
selectWindow("Results");
run("Close");

154

MATLAB Code
clear all
close all
sad = transpose(dir);
s=size(sad)
for n=1:s(2);
wholecell = xlsread(sad(n+2).name);
[rownum,colnum] = size (wholecell);
for a =
len
b =
for

%
%

1:(colnum-1)
= length(wholecell(:,a));
1;
i = 1:len
if wholecell(i,a+1) > 0
donut(b) = wholecell(i,a+1);
b = b+1;
end

end
dl = length(donut); % length of donut vector
for j = 1:dl
op(j) = (j-1)*100/dl;
end
np = 0:1:100;
norm_donut = interp1(op,donut,np);
figure
plot(np,norm_donut,'r', op,donut,'.b')
norm_wholecell(:,a) = norm_donut;

end
avg_wholecell = mean(norm_wholecell, 2);
% plot(np,avg_wholecell)
SD = std(norm_wholecell,0,2);
SE = SD./sqrt(rownum);
wholecell_data = [avg_wholecell, SE];
%write to column then export to excel
xlswrite('FILE LOCATION', TITLE, n+1);
end
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B. Normality Assumptions (from JMP)
Normal quantile plots and one-way Analysis of Residuals are included for each experiment. The
normal quantile plots appear reasonably linear so there is no substantial evidence of nonnormality in the residuals. All data falls within the bounded red lines. Furthermore, slight
differences in variation among the treatment groups are apparent, but the differences are not
extreme. There is no substantial evidence of unequal variance. Independence is met by assuming
each well is an experimental unit.
2D FSM Fluorescence Distribution Trafficking

UV FSM Fluorescence Distribution Trafficking
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BSM p21 Ratios
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FSM p21 Ratios
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FSM, Lysenin, and Ceramide 2D Fluorescence Distribution Trafficking
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